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Abstract 
The activation of the Toll-like receptors (TLRs) on eukaryotic cell membranes results in the cytosolic 
TIR domains coming into close proximity for the binding of adaptor proteins to form a scaffold for 
downstream signalling. MAL/TIRAP (MyD88 (myeloid differentiation primary response gene 88) 
adaptor-like/TIR domain-containing adaptor protein) is the bridging adaptor required for MyD88-
dependent signaling by a number of TLRs including TLR4. Crystal structures of the MAL TIR domain 
(MALTIR) have shown that the structure of the TIR domain is strikingly different to a typical TIR 
domain fold. The MALTIR crystal structure contains a long AB loop situated between the αA helix and 
the βB strand, but no BB loop. This structural re-arrangement has significance as the BB loop in other 
TIR domains has been associated with protein interactions. In addition, four of the seven cysteine 
residues were oxidised in the crystal structures, participating in two disulfide bonds. To understand 
the role of these cysteines, comprehensive biochemical tests and structural characterisation of the 
protein was carried out.  
This thesis presents an NMR solution structure of the MALTIRC116A mutant, which shows a significant 
structural rearrangement compared to the crystal structures. The solution structure of MALTIRC116A 
presented in this thesis shows a typical TIR domain fold with the functionally important long BB-
loop. Strikingly, all seven cysteine residues of this structure appear to be reduced and do not form 
disulfide bonds. This was not surprising given that the cytosol in which the MAL protein resides is 
highly reducing. In addition, all cysteines are amendable to modification, such as glutathionylation, 
and have varying sensitivities in physiological redox conditions. Of particular note, the peak intensity 
of cysteine 91 decreased by 45% when the redox environment was changed from a physiologically 
reducing -225 mV to an oxidising -190 mV, suggesting that this cysteine may play an important 
functional role.  
Further to this, the data presented here shows that the MALTIR resides in a dynamic equilibrium that 
can be shifted between a monomeric and oligomeric state when exposed to different pH, salt, 
temperature, and concentration. The identification of this reversible oligomerisation is remarkable 
and provides a possible mechanism for the regulation of this signalling pathway. Following 
purification, a dimer species can also separated. This species is not in equilibrium with the monomer 
and is not covalently bound to the monomer.  
Similarly to TIR domains, coiled-coil (CC) domains in plants are involved in defence signalling and 
implicated in homotypic interactions. In this thesis, the NMR solution structure of a fragment, 
consisting of residues 6–120, of the wheat steam rust protein Sr33 CC domain is presented. The 
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structure corresponds to a four-helix bundle with a surface-exposed functionally important EDVID 
motif. This is significantly different to the published crystal structure of the closely related CC 
domain from the orthologous barley immunity receptor MLA10 that confers resistance to powdery 
mildew; however, the structures share striking similarity to the more distantly related Rx protein CC 
domain from potato. Biophysical studies demonstrate that in solution, all three structures are 
monomeric and adopt a similar fold. Further to this, data shows that the minimal functional unit 
consists of residues 1–142 and that in planta, self-association correlates strongly with immunity-
induced cell death. Collectively, this work contributes to the structural and functional understanding 
of the CC domains in plants.  
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Preface 
The format of this thesis is somewhat different from a typical thesis format, largely because of the 
broad scope of biological areas covered by the work in the thesis, although throughout focusing on 
the structural biology of innate immune proteins using NMR spectroscopy. Chapter 1 contains a 
manuscript that reviews the evidence of redox processes regulating the human innate immune 
signalling pathways. This provides the background to one part of the thesis, which focuses on the 
human innate immunity protein MAL and the role of its redox-sensitive cysteine residues. To 
introduce other areas not covered in Chapter 1, each of the subsequent chapters contains a separate 
mini-introduction. Similarly, the experimental procedures are described in subsequent chapters, 
rather than gathered into a separate material and methods chapter. Chapter 2 discusses the 
biochemical properties of the MAL protein. The methods used in this chapter are interwoven with 
the results. Part 1 of this chapter outlines the purification of the MAL protein and the redox-sensitive 
properties of the cysteine residues. This study is taken further and discussed in Chapter 3. Part 2 of 
Chapter 2 characterizes the oligomeric properties of MAL. As such, this section contains a discussion 
following these results. Chapter 3 is a manuscript in preparation and contains the most striking 
results regarding the structure of the MAL protein, including its solution three-dimensional 
structure. This chapter is divided into manuscript sections that include the introduction, methods, 
results, discussion and a concluding paragraph. Chapter 4 corresponds to a manuscript in 
preparation describing the structure and biophysical properties of the plant innate immunity protein 
Sr33 coiled-coil domain. This chapter corresponds to collaborative work and includes my NMR 
structural work as the key contribution. Finally, the last chapter entails the conclusions and future 
directions of the work covered in the thesis. Included in this chapter are some preliminary studies 
that have been undertaken as a foundation for future work.  
  
 
Chapter 1 
Introduction 
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1.1 Contribution 
This manuscript is a review, which describes the involvement of redox in the human TLR4 innate 
immune pathways. For this review, I researched the literature and wrote the review. This was 
reviewed and revised by Dr. Mehdi Mobli and Professor Bostjan Kobe.   
 
Bound to be together: redox control and the TLR4 innate immunity pathways 
Peter Lavrencic, Mehdi Mobli, Bostjan Kobe 
 
1.2 Abstract 
The innate immunity system, which includes the Toll-like receptor (TLR) pathways, is an important 
cellular danger-sensing mechanism. Activation of the human TLR4 pathways stimulates the 
production of highly oxidising species that alter the reducing cytosol. The population of reduced 
glutathione is decreased, resulting in the oxidation of reduced thiols in the cytoplasm. The cysteine 
residues on cytosolic proteins are prone to this oxidation and undergo modification by small redox 
molecules that include glutathione and reactive oxygen species (ROS). These modifications of the 
signalling proteins in the TLR4 pathway have been shown to behave as a switch that regulates their 
function. The mechanism of cysteine oxidation and reduction in peroxiredoxin proteins is well 
understood, but this is not the case for other affected TLR signalling proteins. This review explores 
the effect that glutathione and ROS have on the human TLR4 innate immune pathway. 
 
1.3 Background 
The mammalian cell cytosol is maintained in a reduced state by a high concentration of reduced 
glutathione. Strong oxidising molecules such as the reactive oxygen species (ROS) are commonly 
obtained from incomplete metabolism of oxygen during cellular respiration and result in the damage 
and disruption of lipids, proteins and nucleotides. ROS results in the modification and oxidation of 
free thiols in the cytoplasm, including the oxidation of the highly abundant reduced glutathione 
molecules as well as cysteine residues on cytoplasmic proteins. Most of these modifications are 
reversible and give cysteine residues the ability to act like specific and sensitive switches. Such 
modifications have been associated with signalling that stimulates cellular defence, proliferation, 
differentiation and apoptosis. Lipopolysaccharide (LPS) activation of the human Toll-like receptor 
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(TLR) 4 innate immune pathway has been shown to protect the cell from oxidative stress (1). A 
number of signalling proteins in the TLR4 pathway have been identified as specific targets for redox 
modifications. These protein targets are critical for the transduction of the signal that leads to the 
stimulation of pro-inflammatory cytokine transcription factor NF-кB. In this review, we first aim to 
address the role of glutathione as a cytosolic redox regulator, followed by the modifications that can 
occur on cysteine residues of proteins by either glutathione or ROS. Finally, we discuss specific 
protein signalling targets in the human TLR4 pathway that have been identified to result in signalling 
in the presence of oxidation. 
 
1.4 Glutathione: a cytosolic redox buffer 
Organic thiol-containing small molecules contribute to the highly reducing cytosolic environment of 
a cell. This reducing potential is determined by a far higher concentration of a reduced moiety (RSH) 
than the oxidised one (RSSR). The small molecule glutathione is found in a high cytosolic 
concentration of up to 11 mM, and hence is the major contributor to the reducing potential (2). The 
eukaryotic cytosol maintains a high reducing environment, with a reduced-to-oxidised glutathione 
ratio of up to 400:1 (3). The reduced glutathione (GSH) is a tri-peptide (ɤ-L-glutamyl-L-cysteine-
glycine) that contains a thiol that can be oxidised. The glutathione redox pair is characterised by the 
reduced form (GSH), which contains a free thiol, and the oxidised form (GSSG) that connects two 
GSH molecules by a disulfide bond. This oxidised form can be reversed to the reduced GSH by the 
enzyme GSH reductase (4). The redox potential of the glutathione redox pair in the cell cytosol is 
around -240 mV in proliferating cells, around -180 mV in differentiating cells and -160 mV during 
apoptosis (5). During an immune response, the cell is under stress and contains a higher presence of 
oxidative species that increase the redox potential. Biochemically, glutathione is a relatively inert 
molecule; however, with its ability to form the reduced or oxidised species, the molecule has been 
shown to have protective anti-oxidant abilities by modifying cysteine residues on proteins or 
detoxifying reactive molecules. The characteristic of GSH as a nucleophilic reductant allows the 
molecule to capture reactive oxygen and nitrogen species that would otherwise lead to harmful 
effects including protein aggregation, which characterises the basis of neurodegenerative disorders 
such as Alzheimer’s and Parkinsons’s disease (6).  
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1.5 Cysteine residues are tuneable molecular switches 
Most cysteine residues in cytoplasmic proteins have free thiols due to the high concentration and 
reducing nature of GSH. The polarisable sulfur atom provides a platform for diverse functionality and 
highly tuneable reactivity, which is controlled by its solvent accessibility and chemical environment 
that affect its pKa, and the oxidation state of the sulfur atom. Cysteines with a low pKa are far more 
susceptible to post-translational modifications, which are commonly caused by glutathione 
(glutathionylation) or by ROS (Figure 1.1). Studies have shown that decreasing the GSH/GSSG ratio or 
adding the ROS molecule hydrogen peroxide at physiologically relevant concentrations (10–400 µM) 
promotes disulfide-bond formation in proteins that are present in the cytosol. In addition, lower 
GSH/GSSG ratios increase the extent of glutathionylation of cytosolic proteins, suggesting that the 
glutathionylation of proteins could be protecting against irreversible hyper-oxidation (7). 
 
Figure 1.1 Summary of the common redox reactions of cysteine residues in the cytoplasm.                    
1: Reactive thiol that is the key to cysteine function. 2: Disulfide bond formation of two cysteine 
residues. 3: Glutathionylation of a cysteine. 4: Irreversible hyper-oxidation (sulfonic acid).     
 
1.5.1 Glutathionylation  
A number of studies have suggested that protein glutathionylation can act as a rapid reversible 
switch that can regulate signalling pathways, including the human TLR4 immune pathway, in a 
manner that is analogous to phosphorylation (8). The functional role of glutathionylation is 
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dependent on the transfer of GSH to and from cytosolic proteins by the glutathione S-transferase 
(GST) and glutaredoxin proteins. Specifically, the glutathione redox switch has been identified in  the 
cell cytoplasm as an important regulator in the formation of the cytoskeleton (9), the JNK apoptotic 
pathway (10), as well as key human transcription factor NF-кB  regulating cytokine production (11), 
which we will focus on in this review. 
NF-κB is a protein complex that controls the transcription of a broad range of pro-inflammatory 
genes (12). Before activation, a family of inhibitors (IκBs) sequester the transcription factor in the 
cytoplasm. Activation occurs through the IKK (IκB kinase) complex phosphorylating the inhibitory IκB 
protein, allowing the translocation of NF-κB into the nucleus. Hydrogen peroxide-induced 
glutathionylation of nuclear factor IKK-β prevents the activation of NF-кB. The oxidation of IKK-β is 
reversible. The overexpression of glutaredoxin, which reduces the key cysteine 179 by removing 
glutathione, activates IKK-β even in the presence of hydrogen peroxide (11). Similarly, 
glutathionylation of other upstream proteins including AKT (13), PTEN (14) and RAS (15) has been 
shown to represent alternative mechanisms for inhibiting NF-кB signalling.  
The GST variant omega-1-1 (GSTO1-1) is an essential protein involved in the transfer of glutathione 
to and from the TLR4 pathway proteins. The actions of the GSTO1-1 have been shown to generate 
cytosolic ROS, following the activation of the TLR4 pro-inflammatory pathway (16). Furthermore, 
GSTO1-1-deficient macrophages are not responsive to LPS and do not activate NF-кB and the 
NADPH-oxidase NOX1 following TLR4 activation (17). This suggests that the target substrate of 
GSTO1-1 is likely to be in the TLR adaptor protein complex downstream of TLR4 (Figure 1.2). 
Knocking out GSTO1-1 results in the increase of GSH and increase in the total protein that has been 
glutathionylated in macrophage-like cells (17). Unexpectedly, GSTO1-1 is associated with 
glutathionylation when epithelial breast cancer cells are exposed to high levels of S-
nitrosoglutathione (GSNO), followed by subsequent deglutathionlylation catalysis once GSNO is 
depleted (18). Thus, GSTO1-1 deglutathionylates under confluent cellular conditions, but reverts to 
glutathionylation under oxidative stress conditions. 
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Figure 1.2 The role of ROS and glutathione in the TLR4 signal transduction pathway for the activation 
of the pro-inflammatory cytokine transcription factor NF-κB. (    ) indicates the general activation 
pathway, (     ) indicates redox reactions, and (     ) indicates likely glutathionylation by the GSTO1-1 
protein. 
 
1.5.2 ROS molecules 
ROS molecules are often produced in eukaryotic cells by the incomplete metabolism of molecular 
oxygen (O2) during aerobic respiration and include superoxide (·O2
-), hydrogen peroxide (H2O2) and 
hydroxide radical (·OH) (19). These molecules are often dangerous to the cell, resulting in the 
oxidation of lipids, proteins and DNA, hindering their ability to function (20, 21). Unexpectedly, LPS-
induced stimulation of the human immune TLR4 pathway initiates the production of superoxide 
from NOX proteins through the oxidation of NADPH to NADP+ (discussed later). Superoxide is a 
highly unstable molecule with an inability to diffuse through the membrane due to its 
electronegative charge (19-21). Similarly, the hydroxyl radical has a highly indiscriminate reactivity 
with a half-life of only 10-9 s, limiting the molecule to the site of production. Superoxide undergoes 
both spontaneous and superoxide-dismutase-mediated oxidation to form hydrogen peroxide (19). In 
contrast to superoxide, hydrogen peroxide is a relatively poor oxidant that reacts slowly with loosely 
NADP 
NADP 
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bound metals (103–104 M-1.s-1), glutathione (2–10 M-1.s-1) and reduced thiols on cysteine residues at 
a neutral pH (19-21). Given the right protein environment, such as a reactive cysteine thiol, the 
reactivity of hydrogen peroxide to cytosolic protein cysteine residues can increase to 107 M-1.s-1. This, 
together with its ability to diffuse through the membrane, makes hydrogen peroxide a prime 
candidate as a useful signalling ROS molecule in the TLR4 pathway (19-21). 
 
1.5.3 ROS interaction with peroxiredoxins 
Peroxiredoxins are a well-studied example of a class of anti-oxidant proteins with finely tuned 
cysteine residues that are highly sensitive to ROS. Peroxiredoxin proteins are highly efficient 
peroxide-consuming proteins that reduce ROS, while oxidising their own cysteine residues at a rate 
of 107 M-1.s-1 (22-24). They have a conserved active-site fold that undergoes a conformational 
change involving an unfolding event following its activation. The oxidation of the active site cysteine 
brings two cysteine residues, which are initially around 14 Å apart, into close proximity. The 
enzymatic mechanism relies on a conserved cysteine residue in the active site that undergoes 
oxidation from a thiol to a sulfenic acid (SOH) intermediate, which then reacts to form a disulfide 
bond with the thiol of the second cysteine (25) (Figure 1.3). Oxidation of peroxiredoxin proteins 
further leads to the formation of larger oligomeric complexes, which have been shown to stimulate 
the TLR4 pathway to induce inflammatory cytokines exogenously (26, 27). Peroxiredoxins shift 
between a stable homodimer state and a doughnut-shaped decamer that is destabilised by disulfide 
bond formation, due to the local unfolding of the structure surrounding the cysteine residues, 
resulting in a re-modelling of the interacting interface (28). It has been suggested that the decamer 
is oxidised more efficiently (29), whereas dimers are more effectively reduced by thioredoxins (30). 
Recycling of the peroxiredoxin from the disulfide-bonded state into the two-free-thiol state is the 
last step in the cycle. The oxidised thiols are reduced by reacting with a thioredoxin protein, or two 
reduced glutathione molecules (GSH) to make GSSG (4, 31). 
The active cysteine residue C51 of human peroxiredoxin-1 has been shown to hyper-oxidise in sub-
millimolar concentrations of hydrogen peroxide. This oxidation occurs at a rate of 0.072% and 
converts sulfenic acid (SOH) to sulfinic acid (SO2H), with a minority irreversibly oxidising further to 
the sulfonic acid (SO3H) (32). Until recently, the progression to sulfinic acid has been thought to be 
irreversible; however, the discovery of sulfiredoxin proteins has shown that the reaction can be 
reversed in an ATP-hydrolysis-dependent manner (33). The ability of peroxiredoxin proteins to 
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recycle and modify their cysteine residues has shown that these proteins play a wider role in 
endogenous cytoplasmic (34-36) and exogenous TLR4 signalling pathways. 
 
Figure 1.3 Peroxiredoxin redox cycle. Peroxiredoxin (Prx) thiols are oxidised by hydrogen peroxide to 
form a sulfenic acid intermediate, which usually reacts with a cysteine thiol pair to form a disulfide 
bond. The disulfide bond can be recycled by a thioreductase (Trx). Oxidation of the sulfenic acid 
(SOH) can result in a sulfinic acid, which can be reversed by a sulfiredoxin and ATP hydrolysis; 
however, oxidation of sulfinic acid (SO2H) into sulfonic acid (SO3H) is an irreversible reaction (31). 
 
1.6 Redox signalling in the TLR4 pathways 
Induction by LPS or exogenous peroxiredoxin protein simulates the association of TLR4 proteins to 
come into close proximity and produce a platform for a downstream signalling cascade that activates 
the pro-inflammatory transcription factor NF-кB (37). Here we discuss three major pathways, shown 
in Figure 1.2, that utilise small redox molecules (ROS and glutathione) for their signalling to induce 
NF-кB.  
 
1.6.1 MyD88-dependent pathway 
The MyD88-dependent pathway is initiated by an interaction between the cytoplasmic TIR 
(Toll/interleikin-1 receptor) domain of TLR4 and the TIR domains from TLR adaptors MAL and 
MyD88. The structure of MAL is predominantly a TIR domain and acts as a bridging adaptor between 
the receptor and the downstream protein MyD88 (38). The MyD88 protein consists of two domains, 
namely, a TIR domain and a death domain. The TIR domain forms TIR-TIR domain interactions with 
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MAL, while the death domain is involved in Myddosome assembly formation. The crystal structure of 
this assembly solved by Lin et al (39)demonstrates that death domains form the core interface 
between MyD88, and the IRAK (interleukin-1 receptor-associated kinase) proteins with a ratio of 
6:4:4 for MyD88:IRAK4:IRAK2, respectively (39). MyD88 has been associated with all cell-surface 
TLRs (2, 4, and 5) as well as endosomal TLRs 7, 8, and 9, indicating that this is a key molecule in the 
TLR signalling pathway (38). The recruitment of downstream protein TRAF6 (TNF receptor-associated 
factor 6) has been shown to occur by either direct association with MAL, or by the interaction with 
the IRAK complex (Figure 1.2) (40), however, it is unclear what determines this selection, or activates 
signal transduction. A closer examination of the crystal structure of MAL TIR domain suggests a 
possible redox mechanism that could drive this pathway. The crystal structure of the MAL TIR 
domain shows cysteine residues forming two disulfide bonds through cysteines 89-134 and 142-174 
(41-44). The highly reducing environment suggests that these cysteine residues are reduced in the 
cytosol but are prone to oxidation. The regulation of the formation of the TIR-domain assembly is 
unclear; however, recent work by Menon et al. (17) suggests that the glutathione transferase 
GSTO1-1 protein targets these proteins and plays a role in the transfer of glutathione, which act as a 
switch (17).  
 
1.6.2 NOX4-dependent pathway 
NOX proteins have been widely studied in phagocytic cells for their role in the generation of 
superoxide and hydrogen peroxide (45). The discovery of several classes of NOX proteins has found 
that they are specific to cell types and may possess unique functions (46). A study by Park et al (47) 
found that the C-terminal region of the NOX4 protein interacts directly with the cytosolic TIR domain 
of TLR4 upon LPS activation, to stimulate the production of ROS. Another recent study supports this 
and suggests that MyD88 is critical in the activation of NOX proteins, which leads to the production 
of ROS molecules (48). Together, these studies suggest that like the IRAKs, NOX4 also interacts with 
the TLR4-MAL-MyD88 TIR domain scaffold. ROS production has been reported to increase upon LPS 
stimulation, which is a result of the NOX4 protein catalysing the production of superoxide and 
simultaneously forming hydrogen peroxide from molecular oxygen, following the oxidation of 
NADPH (47, 49). Hydrogen peroxide activates the PI3 kinase (phosphatidylinositol-3-kinase), which 
transduces the signal to a G-protein, followed by AKT activation, pro-inflammatory gene expression 
and glucose uptake (50) (Figure 1.3). In vivo data has demonstrated that knocking out the NOX4 
protein results in a 30% decrease of NF-кB activation and no activation of AKT following LPS-
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treatment, suggesting that the production of ROS via the NOX4-dependent pathway is important for 
TLR4 signalling (47). 
 
1.6.3 Endosomal pathway 
Pioneering work by Li et al in 2005, described a mechanism by which NOX2 provides the redox 
signalling molecules for the activation of NF-кB. Results from this study demonstrated that upon the 
activation of the interleukin-1 receptor, interleukin-1β recruits MyD88 and the small GTPase Rac1 at 
the plasma membrane. In vivo experiments demonstrated that Rac1 was required for the 
recruitment of NOX2 to the endosome, while MyD88 induced the formation of the endosome. This 
resulted in the activation of the NOX2 protein in the endosome for the production of ROS molecules, 
which activated the recruitment of the IRAK complex and TRAF6 to the receptor (51). This pathway 
represents a subcellular framework for spatially controlled ROS production by NOX2. The 
recruitment of TRAF6 to the receptor is directly dependent on hydrogen peroxide. The mechanism 
of TRAF6 recruitment is unclear, but possibly results in a redox-dependent modification of either 
TRAF6 or an upstream protein (51).  
 
1.7 Concluding remarks 
Small redox molecules, including glutathione and ROS, play an important role in cell signalling. The 
versatility of cysteine residues is protein-specific and relates to the specific protein function. The 
importance of cysteine reactivity in TLR4 signalling proteins has been identified, however, the 
mechanism in many cases remains elusive. Proteins such as peroxiredoxins provide a mechanistic 
insight into the diversity of oxidising modifications and structural changes that take part during an 
oxidation event. Most of the oxidising modifications, such as glutathionylation, disulfide-bond 
formation and sulfinic acid formation are reversible and are utilised for activation or inhibition of 
protein signalling. This review has focussed on the importance of redox molecules in the human 
TLR4 immune signalling pathway, which is just one of many systems these molecules affect. In this 
and other pathways, there remain many gaps in our understanding of the role of small redox 
molecules that were once thought to be only a hazard to the human cell. 
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The monomeric and oligomeric nature of the MAL TIR domain 
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2.1 Introduction 
The MyD88 adaptor-like (MAL) protein, also known as the Toll/ interleukin-1 receptor (TIR) domain-
containing adaptor protein (TIRAP), is a key player in the Toll-like receptor (TLR) signalling cascade of 
the human immune system. The stimulation of cell surface TLRs results in the cytosolic TIR domains 
from at least two TLRs to come into close proximity and form a scaffold for downstream signalling (1, 
2). The cytosolic MAL protein is recruited upon activation of TLR4 and TLR5, or the combination of 
TLR2 with either TLR 1 or 6 (3-7) (Figure 2.1).  
The MAL adaptor protein contains a phosphatidylinositol-4,5-bisphosphate (PIP-2) binding motif  at 
the N-terminus, which allows the protein to anchor to the plasma membrane (8). The remaining 
protein (residues 79–221) consists of a TIR domain, which acts as a bridging adaptor between the 
cytosolic TIR domain of TLR and the MyD88 signalling protein. This set of interactions is dominated by 
TIR:TIR domain interfaces, which form a platform for downstream signalling proteins such as the 
IRAKs and TRAF6 that in turn activate NF-B and the production of pro-inflammatory cytokines (9) 
(Figure 2.1). Single-nucleotide polymorphisms on the MAL TIR domain have shown to detriment     
NF-B activation and compromise an immune response. The rare D96N mutation results in a protein 
that cannot interact with the downstream MyD88 protein and is thus unable to activate NF-B (10).  
Further to this, individuals who are homozygous for the S180L mutation in the MAL TIR domain are 
more prone to sepsis (11) and do not respond to Haemophilus influenza serotype b vaccine (12), 
while heterozygous individuals have a greater resistance to disease (11). The S180L mutation in 
heterozygous individuals has been shown to be a protective factor against the development of 
pneumococcal disease, bacteremia, malaria and, tuberculosis (13, 14). These studies indicate the 
importance of subtle changes in the early signalling stages of this pathway, leading to significant 
effects during an immune response.   
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Figure 2.1 MyD88-dependent signalling pathway of Toll-like receptors (TLRs) that are present on the 
plasma membrane. Two activated TLRs each consisting of an extra-cellular leucine-rich-repeat (LRR) 
domain and an intracellular TIR domain, form a scaffold for downstream signalling to MAL and 
MyD88 proteins, which interact using TIR domains. The signal is transduced between MyD88 and 
IRAK proteins using death-domains (DD). 
 
Four published crystal structures of the MAL TIR domain (MALTIR) (residues 79–221) protein reveal a 
mixture of reduced and oxidised cysteine residues. All four crystal structures reported two disulfide 
bonds, which form between cysteine residues 89:134 and 142:174 (Figure 2.2) (15-18). The MAL 
protein is localised in the cytosol, which is a reducing environment. Therefore, the presence of 
disulfide bonds in the cytosol is intriguing and suggests a possible regulatory mechanism for the 
signalling of the MALTIR via the redox active cysteine residues.  
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Figure 2.2 Overlay of MALTIR crystal structures from Valkov 2YP2 (green)(15), Lin 3UB2 (blue)(18), 
Snyder 4LQD (purple)(17) and Woo 4FZ5 (yellow)(16), showing a mixture of reduced and oxidised 
cysteine residues in red. 
 
Recent studies have shown that redox molecules, including glutathione and hydrogen peroxide, play 
an integral part in the activation and the regulation of this pathway. The transfer of glutathione to 
and from proteins involved in the early stages of the TLR4 signalling cascade is critical for signal 
transduction following the detection of lipopolysaccharide (LPS). Work by Menon et al (19) has 
demonstrated that knocking out S-glutathione transferase (GST) omega class 1 protein, which is 
responsible for the transfer of glutathione to and from proteins, results in the loss of transcription 
factor NF-B activation (19). Similarly, hydrogen peroxide is a critical component that activates the 
protein TRAF6 downstream (20). On the other hand, the oxidation of cysteine residues on the PTEN 
phosphatase protein, which is involved in regulating PIP-2 levels and mediating the recruitment of 
MAL to the cell membrane, results in the protein becoming inactive (21). In addition, this oxidation 
results in a portion of PTEN forming a higher molecular weight structure that is reversible to 
monomers under reducing conditions (21). 
Results in this chapter reveal that the cysteine residues of monomeric MALTIR are redox-sensitive. In 
addition, MALTIR can be purified as a monomer or a dimer. Interestingly, the two do not appear to be 
in a dynamic equilibrium on timescales measured here, such that if the dimer is isolated using size-
exclusion chromatography and subjected to a subsequent size-exclusion chromatography step, no 
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monomer is detected. Literature suggests that TIR domains are active as dimers (22), however, the 
crystal structure was solved using the purified monomer.  
This chapter will discuss two aspects of MALTIR; part 1 will discuss the redox state of the cysteine 
residues, as well as the dynamic equilibrium between the monomeric and oligomeric states of 
MALTIR in solution, while part 2 will discuss the stable dimer of MALTIR.  
 
2.2 PART 1: The solubility of MALTIR and redox state of its cysteine residues 
2.2.1 MALTIR expressed recombinantly in different cell types has the same purification profile 
The gene encoding the human wild-type MALTIR, consisting of residues 79-221, was cloned into a 
pMCSG7 vector (23). This region was selected as it had previously been studied and led to four 
published crystal structures (Figure 2.2). The protein was expressed as a His-fusion protein and 
purified in three different E. coli cell types (BL-21 [New England Biolabs], SHuffle [New England 
Biolabs] (24), and Origami [Merck Millipore]) using the auto-induction method (25). The protein was 
purified using nickel affinity chromatography followed by incubation with TEV protease to cleave off 
the 6-residue histidine tag. The protein was re-eluted over the nickel column and purified further 
using size-exclusion chromatography [Superdex S75 26/600, GE] into a buffer consisting of 20 mM 
Tris at pH 8.6 with 200 mM NaCl. BL-21 cells have a reducing cytosolic environment, which is similar 
to that in eukaryotic cells. On the other hand, SHuffle and Origami  are strains that have been 
engineered with knock-outs to cytoplasmic reductive pathways, resulting in an oxidative cytosolic 
environment, which promotes the formation of cytoplasmic disulfide bonds (24). Expression of wild-
type MALTIR and subsequent purification under non-reducing conditions resulted in a similar elution 
profile across all E. coli strains tested, when separated by size-exclusion chromatography, as shown 
in Figure 2.3. The major peak eluted at 200 mL with a smaller shoulder peak at 170 mL and a void 
volume peak at 120 mL. Both the major elution and shoulder peaks corresponded to the size of the 
MALTIR monomer, as confirmed by SDS gel shown in Figure 2.3. 
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Figure 2.3 Purification curves of MALTIR using a Superdex 75 26/600 [GE] gel filtration column, 
following expression and purification in three different cell types. 
 
 
Figure 2.4 Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) of MALTIR 
expression in BL-21 cells following size-exclusion chromatography. Each lane represents a 5 mL 
fraction between 160 and 220 mL. 
 
2.2.2 MALTIR undergoes redox change of cysteine residues when exposed to different redox conditions 
Wild-type MALTIR was purified from three types of E. coli cells (BL-21, SHuffle and Origami), each with 
different cytosolic redox environments. Ellman’s reagent  (dithiobisnitrobenzoic acid) (26) was used 
to analyse the proportion of reduced cysteine residues in MALTIR. Ellman’s reagent reacts with 
reduced cysteine thiols to form a disulfide bond and produce a yellow-coloured solution (26). The 
colour became more intense as the number of reduced cysteines reacted with the reagent (26). The 
colour change in solution was measured at 412 nm using a spectrophotometer [NanoDrop, Thermo 
Scientific]. The percent of reduced thiols in solution was used to calculate to the nearest number of 
reduced cysteine residues on MALTIR (Table 2.1). The analysis revealed that expression of MALTIR in 
the reducing cytosolic environment of BL-21 cells resulted, on average, in one oxidised and six 
reduced cysteine residues. By contrast, expression of MALTIR in the SHuffle and Origami cell types 
with a more oxidising cytosolic environment produced three oxidised and four reduced cysteine 
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residues. Exposing MALTIR to the strong oxidising agent hydrogen peroxide resulted in the oxidation 
of all cysteines, while exposure to the reducing agent 1,4-dithiothreitol (DTT) led to the reduction of 
all cysteine residues. These results indicate that the cysteine residues are sensitive to redox changes. 
To better understand which of these cysteines were susceptible to redox change in a physiological 
cell environment, single cysteine mutants were expressed in both the reducing BL-21 and oxidising 
SHuffle cytosolic cell environments. 
Table 2.1 Average number of reduced and oxidised cysteine residues in the MALTIR protein following 
expression in different cell types and exposure to chemicals using Elman’s assay. 
Wild-type MALTIR expression cell or 
chemical condition 
% Reduced Reduced Oxidised 
BL-21 with 10 mM DTT and size-exclusion 
chromatography 
100 7 0 
BL-21 90 6 1 
SHuffle 57 4 3 
Origami 53 4 3 
H2O2 (0.03 mM) 0 0 7 
 
2.2.3 Purification of MALTIR single cysteine mutants in BL-21 cells 
All single cysteine-to-alanine mutants were successfully expressed in E. coli BL-21 cells (which 
contain a reducing cytosol), and purified in one litre of LB media using the same protocol as above by 
nickel affinity and size-exclusion chromatography. Following size-exclusion chromatography, all 
proteins showed a two peak profile on a gel filtration chromatogram [Superdex 75 26/600, GE] as 
shown in Figure 2.5. Mutants expressed very different yields of protein, with C89A, C91A, C116A and 
C134A expressing almost twice as much as C142A, C157A and C174A. The first peak on the 
chromatogram eluted at around 170 mL, while the second peak eluted at 200 mL, except for mutant 
C157A, which eluted at 210 mL. The first peak amounted to around 10% of the second peak. 
Comparatively to other mutants, C89A produced a higher ratio of the first peak compared to second 
peak, suggesting that this mutation could be important for the formation of this product.  
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Figure 2.5 Size-exclusion chromatography curves of wild-type MALTIR and cysteine mutants following 
expression in one litre of E. coli BL-21 cells on a gel filtration column [Superdex 75 26/600, GE]. All 
mutants showed a two-peak elution profile with peaks at around 170 and 200 mL.  
 
2.2.4 Purification of MALTIR single-cysteine mutants expressed in E. coli SHuffle cells 
The size-exclusion chromatograms, using a smaller volume analytical column [Superdex 75 10/300, 
GE], of the MALTIR single cysteine-to-alanine mutants showed distinct differences between the 
mutants following expression in SHuffle cells (Figure 2.6). Protein expression using one litre of LB 
media revealed that mutants C89A and C116A produced relatively high yields compared with the 
rest of the mutants. Mutants C89A, C91A, C116A, C142A and C174A produced a two peak profile 
with a large peak eluting at around 13 mL and the smaller peak eluting at around 11 mL, which was 
consistent with the wild-type protein. Similarly, C157A also showed a two-peak profile, but 
contained a shifted elution peak. Comparatively, C134 showed a shoulder peak at 11 mL, however 
did not elute a major protein peak at 13 mL as the other mutants. Interestingly, expression using the 
SHuffle cell type consistently produced larger shoulder peak from around 7 mL compared to BL-21 
cells.  
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Figure 2.6 Size-exclusion chromatography curves of wild-type MALTIR and cysteine mutants following 
expression in one litre of E. coli SHuffle cells on the analytical gel-filtration column [Superdex 75 
10/300, GE]. Cysteine-to-alanine mutants show varying elution and retention times between 
mutants. 
 
2.2.5 The redox state of the MALTIR cysteine residues varies in cysteine-to-alanine mutants following 
expression in E. coli SHuffle cells 
MALTIR mutants C89A, C116A and C174A all showed 3 oxidised and 3 reduced cysteine residues when 
expressed in E. coli SHuffle cells (Table 2.2). Interestingly, mutating cysteine position 91 resulted in 5 
oxidised and 1 reduced cysteine, while mutating C142 favoured reduction with only 2 oxidised and 4 
reduced cysteine residues. C157A resulted in 41% of reduced cysteine residues in the protein, 
equating to 2.5 out of 6 reduced residues. This showed that some cysteine residues were more 
prone to oxidation than others. The Ellman’s assay provides the average number of cysteine residues 
that have been oxidised as a percentage of all cysteines present. It is therefore possible that a 
proportion of a particular residue is oxidised while the remaining is reduced. To address this issue, 
mass spectrometry was utilised to better understand the residues that were modified and the 
proportion of its population that was undergoing redox change.  
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Table 2.2 Number of reduced and oxidised cysteine residues in the MALTIR mutants following 
production in E. coli SHuffle cells. 
MALTIR protein type Oxidised cysteines Reduced cysteines 
wild-type 3 4 
C89A 3 3 
C91A 5 1 
C116A 3 3 
C134A - - 
C142A 2 4 
C157A 3 – 4 2 – 3 
C174A 3 3 
 
2.2.6 Mass spectrometry detects a disulfide bond in MALTIR 
Intact mass of purified wild-type MALTIR was analysed using TripleTOF 5600 [Sciex] and Orbitrap Elite 
[Thermo] mass spectrometers to determine the presence of disulfide bonds by comparing the 
measured mass of the protein to the theoretically calculated mass. The theoretical mass of reduced 
MALTIR was calculated to be 16006 Da and 16017 Da, for monoisotopic and average masses, 
respectively. The TripleTOF mass analyser detected two species with average masses of 16017 Da 
and 16015 Da, which correspond to the fully reduced MALTIR, as well as a MALTIR species containing 
one disulfide bond. Similarly, the Orbitrap Elite detected a monoisotopic mass of 16004 Da, which 
corresponds to the monoisotopic mass of MALTIR with one disulfide bond. This indicates that 
following expression in the reducing environment of E.coli BL-21 cells, purified MALTIR is present as a 
mixture of two species consisting of a fully reduced form and a species with one disulfide bond. 
 
2.2.7 Cysteine residues of the MALTIR domain are susceptible to modification in an oxidative 
environment 
Purified wild-type MALTIR from E. coli BL-21 cells was exposed to 5 mM oxidised glutathione (GSSG) 
and then subjected to a trypsin digest. The peptides were analysed using mass spectrometry to 
identify which cysteine residues could undergo modifications in a highly oxidised environment. 
Similarly to the Ellman’s reagent, glutathione reacts with the reduced thiols of cysteine residues to 
form a disulfide bond. Unlike Ellman’s reagent, which calculates the average number of oxidised 
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cysteine residues from the population by relying on fluorescence, mass spectrometry is able to 
detect both modified and unmodified population sub-types as a proportion of one another. 
Modification by glutathione was tested at pH 8.6, in which the protein was purified, as well as a 
physiologically more relevant pH of 7.5. A number of modifications were detected, including S-
glutathionylation, dioxidation and dehydroalanine formation, shown in Figure 2.7 B–D. Studies from 
Wang et al (27), and also by Maozziconacci et al (28), suggest that the formation of dehydroalanine 
is readily formed when a cysteine residue is exposed to heat of 30 °C in the pH range of 7.0 to 9.0 
(27, 28). In the experimental setup used in this thesis, it is highly likely that the exposure to this 
temperature at the tested pHs of 7.5 and 8.6 resulted in dehydroalanine formation through this 
mechanism. Taken together, these results show that the cysteine residues of MALTIR are susceptible 
to modifications in solution. NMR was utilised to closely investigate the redox conditions that are 
required for these modifications to take place (Section 3.3.6). Before proceeding with NMR studies, 
protein stability assays were carried out to find experimental conditions that would provide NMR 
spectra of suitable quality.  
 
Table 2.3 Modifications to cysteine residues from wild-type MALTIR at a pH of 7.5 or 8.6 detected 
using mass spectrometry, following the addition of oxidised glutathione.   
Cysteine residue Tris buffer pH 8.6 HEPES buffer pH 7.5 
89 Dehydroalanine Dioxidation 
91 Glutathionylation, Dioxidation 
Glutathionylation, 
Dehydroalanine 
116 Glutathionylation Glutathionylation 
134 Dehydroalanine 
Glutathionylation, 
Dehydroalanine 
142 Glutathionylation, Dioxidation Glutathionylation, Dioxidation 
157 Glutathionylation Glutathionylation 
174 Glutathionylation Glutathionylation 
 
 
 
 
 
28 
 
              
NH2
O
OH
SH
                        
NH2
O
OH
S
S
NH
O
NH
O
OHOH
O
NH2
O
                                                                    
 
              
NH2
O
OH
S
O
O
H
                                             
NH2
O
OH
CH2
            
Figure 2.7 Structure of the amino-acid cysteine (A), and the modifications, S-glutathionylation (B), 
dioxidaton (C) and conversion to dehydroalanine (D).                          
 
2.2.8 Protein solubility is dependent on temperature and concentration 
Solubility assays using the wild-type MALTIR were performed to find an appropriate condition for 
NMR experiments. The variables tested included temperature and concentration. The temperatures 
4, 10, 18, 20, 25 and 37°C were tested, while the concentration ranged from 1.0 to 10.5 mg/mL. 
Overall, the data indicated that the protein was less prone to precipitation at lower concentrations 
than at higher concentrations (Figure 2.8). Similarly, the protein was less prone to precipitation at 
lower temperatures than at higher temperatures (Figure 2.9). Below 10°C, there was no 
precipitation at concentrations below 5.0 mg/mL. By contrast, at a temperature of 25°C, the 
precipitation rate increased with rising protein concentration.  
 
A) B) 
C) D) 
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Figure 2.8 Wild-type MALTIR concentrations at 25°C over a period of 5 days. The graph indicates that 
a higher rate of protein loss is observed at increased concentrations. 
 
 
Figure 2.9 Wild-type MALTIR concentration at varying temperatures. The graph indicates that protein 
concentration is more stable at lower temperatures. 
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2.2.9 Determining a suitable condition for NMR spectroscopy using 15N-labelled wild-type MALTIR 
A compromise between temperature and protein concentration was required to maintain high signal 
intensity for NMR experiments, while keeping the protein stable in solution. Protein expression was 
carried out as described in Section 2.2.1 using E. coli BL-21 cells, however in order to introduce 
isotope labels, the cells were grown in minimal (M9) media (0.1 M KH2PO4, 0.45 M Na2HPH4, 0.09 M 
NaCl, 1× Vitamin solution [ThermoFisher], 3.75×10-6 M Thiamine, 8×10-4 M MgSO4, 4×10
-5 M CaCl2, 
9×10-3 M 15NH4Cl, 0.01 M D-glucose), which contained 100 mg/L of ampicillin as well as 
15N-labelled 
ammonium chloride as the sole source of nitrogen. Protein expression was induced using 1 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG), and the temperature was reduced to 20°C overnight. 
The protein was purified as described in Section 2.2.1, using nickel affinity and size-exclusion 
chromatography. Using the purified 15N-labelled MALTIR protein, three conditions (5 mg/mL at 10°C, 
2.5 mg/mL at 10°C and 2.5 mg/mL at 18°C) were selected based on protein solubility data from 
Section 2.2.8 and the properties of NMR, which indicate that at higher temperatures the molecular 
correlation time is shorter and therefore produces narrower line-widths leading to a more intense 
signal. On the other hand, at lower temperatures, the tumbling rate slows down to produce broader 
lines that are less intense; although at lower temperatures, the amide NH exchange rate with 
solution H+ is slowed down, which improves signal intensity. The protein was measured using 5 mm 
susceptibility matched NMR cells (Shigemi Inc.) and NMR data were acquired using a Bruker Avance 
II spectrometer equipped with a cryogenically cooled probe and operating at a nominal 1H frequency 
of 900 MHz. Data was visualised and analysed using CCPNMR software (29). NMR spectra showed 
that the signal improved when the concentration and temperature increased. Visually, the spectra 
between 5 mg/mL at 10°C and 2.5 mg/mL at 18°C were very similar, with the higher concentration 
showing slightly more signals, (Figure 2.10). The signal difference between 2.5 mg/mL at 10 and 18°C 
was notable. The drop in temperature by 8°C produced less signal, which was visually represented by 
less peaks in the spectrum. The concentration of 2.5 mg/mL at a temperature of 18°C was chosen as 
the best condition that would lay the foundation for future NMR work.  
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Figure 2.10 Overlay of 1H-15N-HSQC spectra of 15N-labelled wild-type MALTIR at: 5 mg/mL at 10°C 
(blue), 2.5 mg/mL at 10°C (green) and 2.5 mg/mL at 18°C (purple).  
 
2.2.10 Determining the location of the cysteine residues in the 1H-15N-HSQC spectrum 
The wild-type MALTIR was expressed in E. coli BL-21 cells, which were grown in M9 media (Section 
2.2.9) with the addition of 15N-labelled ammonium chloride as the sole nitrogen source to produce 
15N-labelled MALTIR. In addition, the protein was also expressed in cysteine auxotroph E. coli bacteria 
where the media was supplemented with unlabelled L-cysteine, as these cells are unable to 
synthesise this amino acid. This resulted in a 15N-labelled amide-backbone of the protein, with 
unlabelled cysteine amino-acids. An overlay of two 1H-15N-HSQC spectra obtained from protein 
expression from these cell types revealed the location of the cysteine residues (Figure 2.11). The 
protein that was expressed in E. coli BL-21 cells (red) revealed peaks that represent 1H-15N 
correlation from atoms corresponding to the amide backbone and side-chains of the MALTIR protein. 
By contrast, the protein that was purified from the E. coli cysteine auxotroph strain and 
supplemented with unlabelled cysteine showed six less resonances (blue). One cysteine residue 
could not be identified. 
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Figure 2.11 Overlay of 1H-15N-HSQC spectra of 15N-labelled wild-type MALTIR with labelled (red) and 
unlabelled cysteine amino acids (blue). The positions of six cysteine amino acids are indicated by 
boxes. 
 
2.2.11 MALTIR precipitation is reversible 
Due to the high sensitivity of the 1H-15N-HSQC experiment, a low concentration of 2.5 mg/mL was 
used; however, at this concentration, the less sensitive triple resonance experiments produced 
insufficient signal intensities and the concentration was increased to 5 mg/mL. From the earlier 
protein stability assays, it was clear that the protein would precipitate more rapidly at higher 
temperatures at increasing concentrations. In light of this, the protein was kept on ice prior to and 
between experiments, which resulted in the recovery of precipitated protein. A schematic of this 
reversible process is shown in Figure 2.12 A–E.  
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Figure 2.12 Visual representation showing that the precipitation of MALTIR following exposure to 
heat is reversible. Image A shows soluble protein at room temperature, which is then exposed to 
~37°C for 10 seconds in image B. This results in the precipitation of the protein as shown in image C. 
Following exposure to 0°C in image D, the protein once again re-solubilises (image E).    
 
2.2.12 Chemical shifts of the cysteine residues 
The wild-type MALTIR amide backbone atoms (15N, 13Cα, 
13Cβ, 
13C’, HN, Hα, Hβ) were assigned using 
triple resonance three-dimensional NMR spectra, which included, HNCACB, CBCA(CO)NH, and HNCO. 
Given that protein precipitation was reversible, the experiments were conducted at 18°C at 5 mg/mL 
overnight and placed in the 4°C fridge during the day to re-solubilise. Sample recovery was 
confirmed by 1H-15N-HSQC experiments and overlayed with the initial 1H-15N-HSQC to show that the 
protein was unchanged. Although this process of reviving the precipitated protein was used, wild-
type MALTIR still provided only limited data due to its solubility over a limited time span of 12 hours. 
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Using the CBCA(CO)NH experiment, the chemical shifts of the carbon-β atoms on the cysteine 
residues were determined. Early work by Sharma et al in 2000 (30), and later validated by Martin et 
al in 2010 (31), showed that the chemical shift of the carbon-β atom is highly sensitive to the redox 
state of the neighbouring sulfur atom, and could therefore be used to determine the residue’s redox 
state (30). A carbon-β shift greater than 34.5 ppm correlated with oxidised state, whereas a shift less 
than 32.5 ppm was consistent with a reduced cysteine residue (30). Chemical shifts between 32.5 
and 34.5 ppm could be reduced or oxidised, depending on the secondary structure location of the 
cysteine and neighbouring residues. Six of the cysteines were identified on the 1H-15N-HSQC (Section 
2.2.10), while the seventh cysteine was identified at a lower pH of 7.5 following experiment in 
Section 3.3.5, which revealed extra peaks. In the wild-type MALTIR protein, six of the seven cysteine 
residues contained a chemical shift that was consistent with the reduced redox state, shown in Table 
2.4, while one cysteine (C116) was undefined with a carbon-β shift of 33.4 ppm. This result is 
consistent with mass spectrometry data (Section 2.2.6), which detected a mass corresponding to a 
fully reduced species and another species containing one disulfide bond. Part one of this chapter has 
indicated that the cysteines of MALTIR are susceptible to change following different redox conditions. 
Further structural analysis and physiological relevance is discussed in Chapter 3.  
Table 2.4 Cysteine carbon-β shifts of wild-type MALTIR following expression in BL-21 E. coli cells 
Cysteine residue 
Carbon β shift 
(ppm) 
Redox state 
(<32.5 ppm = reduced) 
89 28.3 Reduced 
91 28.5 Reduced 
116 33.4 Reduced or oxidised 
134 29.5 Reduced 
142 31.2 Reduced 
157 28.5 Reduced 
174 29.0 Reduced 
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2.3 PART 2: Dimer formation of MALTIR 
The purification of the wild-type MALTIR domain from E. coli BL-21, Shuffle and Origami cells all 
displayed a similar size-exclusion elution chromatogram, which depicted a higher molecular weight 
product eluting earlier at 170 mL, as compared to the major product, which eluted at 200 mL 
(Section 2.2.1). Repurifying this first peak at 170 mL over size-exclusion chromatography elutes a 
single peak at a volume of 170 mL. This suggests that the MALTIR protein could be forming a stable 
higher oligomeric state.  
 
2.3.1 MALTIR oligomer is not covalently bonded 
Following size-exclusion chromatography of MALTIR (Section 2.2.1), a higher molecular weight 
(HMW) peak, which elutes at 170 mL, was run on 12% SDS PAGE with or without reducing agent 
(DTT) and compared to the major elution peak at 200 mL that was confirmed to be the monomer of 
MALTIR (Figure 2.13). All lanes showed a major band at an estimated 15 kDa, which corresponded to 
the expected size for the monomeric MALTIR protein. A faint band is observed at around 25 kDa in 
samples corresponding to the smaller elution peak 170 mL, suggesting a stable dimeric product. 
Overall, no significant changes occurred with and without the addition of reducing agent, suggesting 
that dimer or oligomer formation between MALTIR monomers is not likely to be stabilised by covalent 
bonds between cysteine residues.  
 
Figure 2.13 SDS PAGE of wild-type MALTIR monomer and higher molecular weight (HMW) species, 
reduced and non-reduced. 1) Monomer, 2) Monomer with DTT, 3) HMW species, 4) HMW species 
with DTT. 
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2.3.2 Higher molecular weight species of the MALTIR domain is a salt independent interaction 
To investigate the effect of salt on the ability of MALTIR to form stable homo-dimers, the protein was 
separated by size-exclusion chromatography using the analytical gel-filtration column [GE] in either 
no salt or a salt concentration of 500 mM. The salt concentration had no significant effect on the 
elution profile of MALTIR, with both chromatograms showing a very similar elution profile          
(Figure 2.14).  
 
Figure 2.14 Size-exclusion chromatogram of MALTIR purified with either: A) 0 mM salt or B) 500 mM 
salt. 
 
2.3.3 Size and shape analysis the MALTIR domain monomer and higher molecular weight moiety 
Both smaller shoulder peak and the major elution peaks from size-exclusion chromatography were 
analysed by small angle X-ray scattering (SAXS) to confirm the size of the higher molecular weight 
elution product. The molecular weight calculated from the scattering of the major peak was 
consistent with the monomer, and was compared to the crystal structure determined by Valkov et al 
(15) using FoXS (32) (Figure 2.15). The goodness-of-fit is evaluated by a χ-metric, which is the 
normalised sum of the squares of the residuals of the predicted and experimental data, divided by 
the experimental errors (32). A χ-value of 1 constitutes a perfect fit to the data, although this is 
difficult to achieve in practice due to challenges in estimation of the errors (33, 34). In this case, the 
MALTIR crystal structure alone is not sufficient to reproduce the scattering (χ = 3.8), although the 
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agreement was improved by the addition of the missing AB loop (χ = 2.4). However, the fits are 
close, suggesting that the predominant members of the solution ensemble are similar in shape.   
Furthermore, the smaller shoulder peak that elutes before the monomer (Figure 2.3), corresponded 
to the molecular weight for a MALTIR dimer. The dimeric arrangement using two monomer interfaces 
in the crystal was not consistent with the scattering (χ = 13.54 and 15.30) (Figure 2.16). Rigid body 
modelling using two copies of the crystallographic monomer improved this to χ = 4.31, but an ideal 
fit was still not achieved (Figure 2.17). This indicates that the dimer interface of the purified dimer is 
different to that observed between the monomers in the protein crystal, but also that minor 
conformational changes in the monomer may be present. 
 
 
Figure 2.15 A) SAXS curves showing the experimental plot of MALTIR monomer with (blue) and 
without (green) added loop; chi= 2.4 and 3.8, respectively. B) Rigid body modelling of SAXS data 
using the MALTIR monomer crystal structure from Valkov et al (15). 
 
 
 
 
 
 
 
A)  B) 
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Figure 2.16 A) Comparison of the experimentally measured SAXS curve (black) and two theoretically 
generated curves based on two crystal interfaces from protein crystal of MALTIR (red and blue).        
B) Visual representation of the two dimer interfaces detected in the protein crystal of MALTIR (15). 
 
 
Figure 2.17 A) Experimental SAXS curve (black) of MALTIR dimer with different models for the 
interaction interface. B) Model of different dimer arrangements that fit experimental SAXS data. 
Colours represent different models. 
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2.3.4 Crystallisation of the MALTIR dimer 
Evidence from SAXS confirmed that a dimeric species was present, however the nature of the dimer 
interface remained unclear. Crystallography was attempted to determine the structure of the MALTIR 
dimer. MALTIRC116A mutant was used for screening as this mutant produced a higher yield of this 
dimer compared to the wild-type (Section 2.2.3). Initial grid screen conditions were tested using 
commercially available screens including: PEG/Ion and PEGRx [Hampton Research] and Pact Premier 
and JCSG+ [Molecular Dimensions]. Grid screens were then designed around the most promising 
conditions. These promising conditions were tested using varying precipitant, pH, salt, and reducing 
agent (Table 2.5). One condition that was composed of 10% PEG 1000 with 1 mM DTT, produced 
small needle-like crystals following 10 days incubation at 18°C, which are shown in Figure 2.18. 
These crystals were too small to test diffraction by X-rays, and in conjunction with the small yield 
following purification of the dimer, made it difficult to study.  
Table 2.5 Conditions tested for the crystal formation of the MALTIR dimer      
Condition Range 
PEG type 400, 1000, 3500, 6000, 8000 
PEG concentration 0 – 12 % 
pH 6 – 10 
NaCl 0 – 200 mM 
MgSO4 150 – 600 mM 
Metal additives MgSO4, MgCl2, ZnCl2, ZnSO4 
Methods Hanging drop, sitting drop, streak seeding 
Protein to buffer drop ratio 3:1, 2:1, 1:1 
DTT With/ without 
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Figure 2.18 Small needle-like crystals of MALTIRC116A dimer obtained in 10% polyethylene glycol 1000 
with 1 mM DTT following 10 days incubation at 18°C. 
 
2.4 Summary: Proposed model for MALTIR oligomerisation 
Based on the compilation of results presented in this chapter, the human MALTIR exists in a dynamic 
equilibrium in solution between a monomer and higher oligomeric state (Figure 2.19). The formation 
of the oligomeric state is dependent on a combination of protein concentration (> 2 mg/mL) and 
temperature (> 10°C) at a neutral pH. These conditions are inter-related and the equilibrium can be 
shifted by changing any one of these conditions. Following the purification of soluble MALTIR, around 
10% of protein purifies as an irreversible dimer. The monomeric interface of this dimer is unknown, 
however, it is unlikely that covalent interactions between cysteine thiols play a role. In addition, salt 
concentrations of zero and 500 mM do not appear to influence dissociation of the dimer.  
Results presented here are consistent with the paradigm of higher order assembly formation (35-
38). The formation of an oligomeric complex requires a seed and a favourable condition that 
stabilises further polymerisation. The formation of the oligomer is determined by a sigmoidal curve 
that is a function of concentration (35). The stable MALTIR dimer presented in this chapter could 
suggest a role for this molecule as the initial seed, upon which the oligomer can build when 
conditions are favourable to stimulate a response. For example, the study by Tay et al (39) has 
shown that activation is induced once a critical mass is reached, initiating an all-or-nothing response. 
Tay et al reported on tumor necrosis factor-alpha (TNF-α)-induced NF-B activation using TNF-α 
concentrations that spanned over four orders of magnitude (39). NF-B was activated once a critical 
threshold of TNF-α was reached, with a greater number of mammalian cells switching on a response 
at higher concentrations of TNF-α (39). Further to this, higher order assemblies amplify signal while 
200 µm 
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reducing biological noise. The higher order assembly paradigm suggests that without larger 
assemblies, the signal transduction is thermodynamically and kinetically less efficient with transient 
fluctuations in concentration, diffusion, and protein conformation (35). 
A striking feature of the MALTIR oligomer demonstrated in this chapter (Figure 2.12) shows its ability 
to reverse into soluble monomers. This novel feature of MALTIR suggests a possible regulation of the 
signalling mechanism for the protein. Association of TIR domains has been reported to promote 
signalling, such as in TLRs. A study done by Ve et al (unpublished) confirmed that MAL formed the 
oligomer by fitting monomers into an electron density map produced by electron microscopy. A 
similar feature for reversible oligomers was first reported by Motshwene et al (40), between 
downstream protein MyD88 and its binding partners IRAKs; a complex that was later crystallized by 
Lin et al (41). This interaction constitutes death-domain interactions, which form a helical assembly 
at increasing concentrations. Interestingly, MyD88 is also prone to self-association. This process 
could be controlled with the addition of 50 mM salt and reducing agent (40). Given that the 
downstream signalling protein MyD88 reversibly self-associates and forms a complex with IRAK 
proteins 4 and 2, it is likely that the reversible oligomer observed in MALTIR is a physiologically 
relevant event, providing a scaffold for efficient downstream signalling.  
The observations made here are critical, particularly early in TLR signalling during the TIR domain 
interactions of TLR, MAL, and MyD88. Higher-order assemblies between these proteins, especially 
MAL as shown through the results in this chapter, would allow for an efficient transfer and 
amplification of signalling to downstream molecules such as the IRAK complex.  
 
 
Figure 2.19 A model showing conditions that determine the dynamic equilibrium of the monomeric 
and dimeric states of the MALTIR protein, as well as conditions that lead to the irreversible 
denaturation of the protein.   
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Chapter 3 
Solution structure of the TLR adaptor MAL/TIRAP TIR domain 
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3.1 Contribution 
Chapter 3 includes a manuscript titled, “Solution structure of the TLR adaptor MAL/TIRAP TIR domain 
in the reduced state reveals large structural rearrangements upon disulfide-bond formation,” which 
will be submitted shortly for publication. In this piece of work, I expressed and purified all MALTIR 
constructs, prepared all samples for NMR spectroscopy, assigned 1H, 15N, 13C resonances to wild-type 
MALTIR and the C116A mutant, refined the structure of MALTIRC116A, wrote the manuscript, and 
created the figures. All authors contributed to critical analysis and review of the manuscript. 
  
Solution structure of the TLR adaptor MAL/TIRAP TIR domain in the reduced 
state reveals large structural rearrangements upon disulfide-bond formation 
Peter Lavrencic1,2, Mehdi Mobli2, Bostjan Kobe1 
1School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian 
Infectious Diseases Research Centre, University of Queensland, Brisbane, Queensland 4072, 
Australia. 2Centre for Advanced Imaging, University of Queensland, Brisbane, Queensland 4072, 
Australia. 
 
3.2 Introduction 
Toll-like receptors (TLRs) serve as innate immune sensors for microbial stimuli such as bacterial lipids 
and nucleic acids (1). These microbial molecules bind to the extracellular domains of the receptors, 
inducing their oligomerization, including the association of their intramolecular TIR (Toll/interlekin-1 
receptor/resistance protein) domains (2). The associated receptor TIR domains serve as a scaffold 
for the binding of TIR domain-containing adaptor proteins and effector enzymes in the cytosol, 
eventually leading to a broad range of inflammatory and antimicrobial responses, as well as the 
maturation of the adaptive immune response.  
The ten human TLRs each use a specific combination of four TIR domain-containing adaptors to 
activate specific sets of signaling pathways (3). All TLRs except TLR3 activate the 'MyD88-dependent 
pathway', through binding the adaptor MyD88 (myeloid differentiation primary response gene 88), 
either directly or with the help of the bridging adaptor MAL (MyD88-adaptor-like), also known as 
TIRAP (TIR-domain containing adaptor protein).  MAL is used by TLR4, TLR5, and TLR2 in combination 
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with TLR1 or TLR6.  The alternative, ‘TRIF (TIR domain-containing adaptor inducing interferon-β)-
dependent pathway’ is activated either by TRIF binding directly to TLR3, or indirectly to TLR4 with 
the help of the bridging adaptor TRAM (TRIF-related adaptor molecule). The relevance of MAL to 
human disease is highlighted by the effect of a number of SNPs in its gene on the susceptibility to 
infectious disease or autoimmunity (3).   
The TIR domains typically comprise 125–200 residues with an alternating -strand/-helix 
arrangement of secondary structure elements, resulting in a central five-stranded parallel -sheet 
(strands A–E) surrounded by five -helices (A–E) on both sides of the sheet (2). The loops are 
usually named based on the elements of secondary structure they connect; for example, the ‘BB 
loop’ connects strand B and helix B. In addition to TLRs and TLR adaptors, TIR domains are found 
in interleukin-1 receptors, plant innate immune proteins and bacterial proteins (some of which 
interfere with the host innate immune responses) (2). TIR domains generally function through 
homotypic protein:protein interactions with other TIR domains. MAL contains a TIR domain at the C-
terminus, and a short N-terminal region that contains a PIP2 (phosphatidylinositol 4,5-biphosphate)-
binding motif and is responsible for its membrane localization (4).  
The crystal structures of the TIR domain of MAL, as well as the crystal structures of two disease-
associated mutants (S180L and D96N), have been reported independently by four groups (5-8). All of 
these structures consistently show unique features compared to other TIR domains. In particular, 
these structures lack helix αB and feature a long AB loop situated between the helix αA and the β-
strand βB, which includes the conserved and functionally important BB-loop proline-containing motif 
(9-11). Furthermore, these crystal structures contain two disulfide bonds involving residues 
C89:C134 and C142:C174, respectively. The presence of these disulfides is unusual for a cytosolic 
protein and poses an intriguing possibility of redox control of MAL-mediated signalling (12).  
To shed light on the role of cysteine residues in the structure and function of MAL, comprehensive 
biochemical and structural characterization of the protein was carried out. Here, data is presented 
showing that the recombinantly-produced protein does not contain disulfides, but several of its 
cysteines are highly reactive. The solution structure of the reduced form of the MAL TIR domain was 
determined (residues 79–221; MALTIR) by nuclear magnetic resonance (NMR) spectroscopy, revealing 
a more typical TIR-domain fold compared to the crystal structure, and uncovering a remarkable 
structural rearrangement upon disulfide formation that includes the relocation of a -strand and 
repositioning of the BB-loop motif. 
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3.3 Methods 
3.3.1 Expression and purification of MALTIR and its cysteine mutants 
BL-21, SHuffle (New England Biolabs) or Origami (Merck Millipore) Escherischia coli cells were 
transformed by heat-shock with the pMCSG7 vector (13) encoding wild-type MALTIR  (residues 79–
221) or its mutants C89A, C91A, C116A, C134A, C142A, C157A and C174A. The cells were then grown 
in a 50 mL starter culture of LB media with 100 mg/L of ampicillin overnight at 37°C. Cells were 
centrifuged at 800 x g and washed in M9 salts. One mL of starter culture was added to each flask 
containing 500 mL auto-induction media (14), with 15N-labeled ammonium chloride added for the 
expression of 15N-labeled protein (15), and grown while shaking at 37°C until the OD of each flask 
reached an absorbance of 0.8 at the wavelength of 600 nm. Once the OD was reached, the 
temperature was reduced to 20°C for overnight protein expression. The cells were then lysed by 
sonication, and the protein was purified using nickel-affinity chromatography. TEV (tobacco etch 
virus) protease was added to the protein for overnight incubation at 4oC to cleave the 6-histidine tag 
from the protein. The protein was further purified by re-eluting over the nickel affinity column, 
followed by size-exclusion chromatography with a Superdex 75 gel-filtration column (GE Healthcare 
26/600 S75) into a buffer consisting of 20 mM Tris-HCl (pH 8.6) with 200 mM NaCl.  
 
3.3.2 Expression and purification of 15N and 13C-labelled MALTIRC116A 
The plasmid coding for the C116A mutant of MALTIR (MALTIRC116A) was transformed into E. coli BL-21 
cells by heat-shock, and grown overnight in a starter culture of Luria’s broth (LB) in the presence of 
100 mg/L ampicillin while shaking at 37°C. The protein was then expressed in the LB media while 
shaking at 37°C until the cells reached an optical density (OD) of 0.7 at the wavelength of 600 nm. 
The sample was centrifuged at 800 x g, washed in M9 salts (Section 2.2.9) and resuspended in 
minimal M9 media (Section 2.2.9) containing 13C glucose and 15N ammonium chloride until the cell 
density reached an OD of 0.8 at the wavelength of 600 nm. The temperature was then reduced to 
20°C and the cells were induced with 1 mM isopropyl-1-thiogalactopyrano-side (IPTG) for overnight 
expression. The protein was purified as described above. 
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3.3.3 NMR data acquisition 
300 L of 13C/15N-labelled MALTIR sample containing 5% D2O was added to a susceptibility-matched 5 
mm outer-diameter microtube (Shigemi Inc., Japan). NMR data for wild-type MALTIR was acquired 
using a concentration of 168 µM of protein in Tris buffer at pH of 8.6 with 200 mM NaCl. A 
MALTIRC116A mutant sample was prepared at a protein concentration of 600 µM of protein in TRIS 
buffer at pH of 8.6 with 200 mM NaCl. 
 
NMR data were acquired at 18˚C using a 900 MHz AVANCE spectrometer (Bruker BioSpin, Germany) 
equipped with a cryogenically cooled probe. Data used for resonance assignment were acquired 
using non-uniform sampling (NUS); sampling schedules that approximated the rate of signal decay 
along the various indirect dimensions were generated using sched3D (16). The decay rates used 
were 1 Hz for all constant-time 15N dimensions, 30 Hz for all 13C dimensions, and 15 Hz for the semi-
constant indirect 1H dimension of the HBHA(CO)NH experiment. All pulse programs were executed in 
NUS mode on Topspin 3.2. 13C- and 15N-edited HSQC-NOESY experiments were acquired using linear 
sampling. Separate experiments were acquired for the aliphatic and aromatic regions of the 13C 
dimension. The low concentration of wild-type MALTIR protein and the high pH and salt 
concentrations resulted in very poor signal-to-noise ratios and despite extensive signal averaging 
(128 scans per increment), the assignment rate using the HNCACB/CBCA(CO)NH, HNCO/HN(CA)CO 
and HNCA/HN(CO)CA sets of spectra did not yield high levels of assignments and further 
experiments for side-chain and NOE assignments were not undertaken.  
 
MALTIRC116A at the high concentration of 600 µM was found to remain mostly monomeric for ~18 
hours, after which the signal intensities in the NMR spectra would broaden significantly due to self-
association. The self-association could be reversed completely when the sample was incubated at 
4˚C. The NMR data for this sample were therefore acquired in 16‒20 hour segments. The HNCACB, 
HBHA(CO)NH, 15N-HSQC-NOESY and 13C-HSQC-NOESY (aliphatic region) were acquired as 3 sections, 
the CBCA(CO)NH, HN(CA)CO, H(C)CH and 13C-HSQC-NOESY (aromatic region) as 2 sections and the 
HNCO as a single section (~18 days of acquisition time at 900 MHz). The segments were co-added in 
the time domain prior to reconstruction, either using traditional processing methods (linear 
prediction, apodisation, zerofilling followed by Fourier transform) or using automated maximum 
entropy reconstruction as described previously (17).  
 
NMR spectra were analysed and assigned using the program CCPNMR (18). 1HN, 
15N, 13C, 
13C, and 
13C resonance assignments were obtained from analysis of amide-proton strips in 3D HNCA, 
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HN(CO)CA, HNCACB, CBCA(CO)NH, HN(CA)CO and HNCO spectra. Side-chain 1H and 13C chemical 
shifts were obtained primarily from a 3D H(C)CH-TOCSY and the remaining side-chain assignments 
were derived from 3D and 15N- and 13C-edited NOESY-HSQC spectra. Several segments (generally 
loop segments) of the protein could not be assigned due to either line broadening from 
conformational exchange or unfavourable NH exchange at the high pH required. The following 
sections/residues could not be assigned: 79–86, 100, 111, 125, 127, 131–133, 169, 170, 183, 184, 
192–197, 201, 202, 206, 207. This resulted in an overall assignment rate of 72% of all 1H atoms. 
 
3.3.4 Structure determination 
Distance restraints for structure calculations were derived from 3D 13C- and 15N-edited NOESY-HSQC 
spectra acquired with a mixing time of 90 ms. NOESY spectra were manually peak picked and 
integrated. The peak lists were then assigned and an ensemble of structures calculated 
automatically using the torsion angle dynamics package CYANA (19,20). The tolerances used for 
CANDID were 0.03 ppm in the indirect 1H dimension, 0.02 ppm in the direct 1H dimension and        
0.4 ppm for the heteronuclei (13C and 15N).  
 
Backbone dihedral-angle restraints (106  and 110 for ) were derived from TALOS+ chemical shift 
analysis (21,22); the restraint range was set to twice the estimated standard deviation. All X-Pro 
peptide bonds were clearly identified as trans on the basis of the C and Cγ chemical shifts for the 
Pro residues. 
 
CYANA was used to calculate 200 structures from random starting conformations, then the 20 
conformers with the lowest CYANA target function were chosen to represent the structural 
ensemble. During the automated NOESY assignment/structure calculation process, CYANA assigned 
~80% of all NOESY crosspeaks (2648 out of 3398) for MALTIRC116A. The short mixing time minimises 
spin diffusion effects and the relatively large fraction of unassigned NOEs is consistent with the 
relatively high percentage of unassigned atoms (~28%).  
 
3.3.5 NMR of MALTIR at varying pH values 
To compare the effect of pH on the structure of MALTIR, the 15N-labelled MALTIRC116A was divided and 
buffer-exchanged into three buffers, each made of 10 mM HEPES and 50 mM NaCl, at pH 7.5, 8.0 or 
8.6. The chemical shifts of 1H and 15N were measured at each pH value and analysed using the 
program CCPNMR (18).  
 
 
52 
 
3.3.6 Determination of redox shifts of cysteines in wild-type MALTIR 
Stock solutions of reduced (GSH) and oxidised (GSSG) glutathione were made in 10 mM HEPES buffer 
and adjusted to pH 7.5. Nitrogen was bubbled through both solutions to remove oxygen. A 1H 
spectrum of each stock was measured using a 900 MHz magnet and analysed using the 
spectrometer software (TopSpin 3.2) to confirm whether the stock solution redox species were 
indeed reduced or oxidised. Purified 15N-labelled wild-type MALTIR in a 10 mM HEPES (pH 7.5) buffer 
was added to 5 different buffers containing varying ratios of GSH:GSSG that equate to specific 
electrochemical potentials (GSH only, -225 mV, -198.67 mV, -189.77 mV and GSSG only). 
Electrochemical potential was calculated using the Nernst equation E° = E°GSH/GSSG – (RT/nF) ln(Keq), 
where E°GSH/GSSG is the standard potential of glutathione at pH 7.5 (-240 mV) (23), R is the universal 
gas constant (8.314 J K-1 m-1), T is the absolute temperature, n is the number of electrons 
transferred, F is Faraday constant (9.648 × 104 C mol-1), and Keq is the equilibrium constant 
([GSH]2/GSSG). A 1H-15N-HSQC was completed for each of the redox conditions at 298 K using a     
900 MHz magnet to determine the chemical shifts of each residue. 
 
3.3.7 Analysis of chemical shifts of 1H and 15N atoms 
Changes in chemical shifts were quantified using the Euclidean method for distance measurements, 
following the frequency assignment of 1H and 15N atoms in each 1H-15N-HSQC experiment            
using the CCPNMR software (18). Individual residues were compared using d2, where                                  
d(𝑝1, 𝑝2)
2 = (𝐻1 −𝐻2)
2 + (𝑁1 −𝑁2)
2. Overall comparison between data-sets was calculated       
using root-mean-square deviation (RMSD); where RMSD =√
1
𝑛
∑𝑑(𝑝1, 𝑝2)    . 
 
3.3.8 Reactivity of cysteine residues 
Intensities of peaks assigned to cysteine residues 89, 91, 116, 134, 142, 157 and 174 were measured 
in 1H-15N-HSQC spectra at redox potentials of -225, -199 and -190 mV using purified 15N, 13C wild-
type MALTIR. To account for changes in peak intensities due to variations in sample conditions, such 
as the salt concentration, which impact on magnetic susceptibility, conductivity, and correlation 
time, the intensities of 12 peaks corresponding to atoms at coordinates distal to the cysteine 
residues in the 3D structure were monitored. Intensity changes of these unreactive sites were 
averaged and applied to the measured cysteine residue intensities as a normalisation factor.  
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3.4 Results 
3.4.1 Secondary structure of MALTIR in solution is different to that in the crystal structure 
The amide-backbone of purified 13C and 15N-labelled wild-type MALTIR provided limited data due to 
its inherent insolubility as discussed in Chapter 2. Secondary structure prediction of the limited 
chemical shifts obtained from the wild-type MALTIR using TALOS+ indicated that there is a major 
structural rearrangement between residues 111 and 138, compared to that of the crystal structure 
(Figure 3.1). The crystal structures indicated that this region of the protein formed a long loop, called 
AB-loop, with high flexibility (5-8). The predicted solution structure suggested the formation of a Bβ-
strand followed by a BB loop, which is a key feature in typical TIR domain folds (2). This result 
prompted further investigation to find a mutant of MALTIR that would be soluble for the length of the 
experiment, to gain better quality data for structural analysis by NMR.   
 
Figure 3.1 Comparison of the predicted secondary structure of wild-type MALTIR in solution from 
amide back-bone chemical shifts using TALOS+, and crystal structure. (--) missing chemical shifts,       
( ) α-helix, ( ) β-strand. Red residues indicate the region with a major structural rearrangement 
between the two structures. 
 
3.4.2 Single cysteine mutations have varying impacts on the MAL structure  
Purified wild-type MALTIR provided limited data due to its tendency to precipitate in solution at high 
concentrations over a span of 12 hours at 18°C. To study the structural features of MALTIR, cysteine-
to-alanine mutants were explored to find a protein that retained the wild-type fold while remaining 
soluble for the length of the experiment. Overall, most cysteine-to-alanine mutants of MALTIR 
retained a structure similar to the wild-type protein, as demonstrated by minor chemical shift 
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differences between the atoms of mutants and the wild-type protein (Table 3.1). The RMSDs for the 
cysteine mutants compared to the wild-type protein ranged from 0.028 to 0.120 ppm, with C89A 
having the lowest perturbation and C157A the highest. Neighbouring residues were not included in 
the calculation, to minimise the local effect of the mutations on the chemical shifts of the protein. 
The mutant C157A displayed a consistently high 1H and 15N displacement, with eight residues 
throughout the protein backbone containing shifts over 0.2 ppm (Appendix Figure 3.6). By contrast, 
the C116A mutant had an RMSD of 0.058 ppm compared to the wild-type protein and contained 
only three 1H-15N shifts over 0.2 ppm. Two of these are either neighbouring (R115; shift of 0.46 ppm) 
or in close spatial proximity (D87; shift of 0.227 ppm) to the mutant residue. The mutants C89A, 
C134A and C142A contained no 1H-15N shifts over 0.2 ppm, with RMSD values of 0.033, 0.028 and 
0.042 ppm, respectively, when compared to the wild-type protein, while C91A and C174A each 
contained one residue over 0.2 ppm, but maintained low RMSD values of 0.050 and 0.045 ppm, 
respectively, when compared to the wild-type protein.  
Solubility of MALTIR mutants was analysed by measuring a 1H-15N-HSQC spectrum at day zero and 
again at day six following incubation at 25°C. Mutants C89A and C116A remained soluble over this 
time period while the rest of the mutants formed precipitates in solution. 1H-15N-HSQC analysis 
revealed that C116A produced very minor differences following a 6 day incubation at 25°C. Given 
that C116A retained similar fold to the wild-type (Figure 3.2), remained soluble for a 6 day period 
(Figure 3.3), expressed well (section 2.2.3), and did not involve any disulphide bonds in the crystal 
structure that would bias this structure away from the crystal structure, this mutant was chosen for 
structural studies. 
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Table 3.1 RMSD values of cysteine-to-alanine mutants of MALTIR compared to the wild-type protein, 
calculated using Eucladian norm. 
Cysteine mutant RMSD (ppm) 
C89A 0.033 
C91A 0.050 
C116A 0.058 
C134A 0.028 
C142A 0.042 
C157A 0.120 
C174A 0.045 
See Appendix Figures 3.1–3.7 for residue-by-residue chemical shift comparison to the wild-type 
protein. Neighbouring residues of the mutation were not included in this calculation to minimise 
local effects on the protein. 
  
 
Figure 3.2 Overlay of 1H-15N-HSQC spectra from MALTIRC116A (blue) and wild-type MALTIR (cyan). Most 
chemical shifts of 1H and 15N are conserved between the spectra, with a large shift detected for the 
mutated C116 residue, the neighbouring residue R115 and additionally, residue D87. 
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Figure 3.3 Overlay of 1H-15N-HSQC spectra of MALTIRC116A measured at 18°C (blue) at time 0, and after 
6 days, measured at 25°C (purple). The overlay of spectra shows that the fold of the protein has 
been retained. The spectra have been shifted by 0.1 ppm in the 1H axis to aid comparison. 
 
3.4.3 Chemical shifts of the cysteine residues 
The chemical shift of the carbon-β atom of the cysteine residues in MALTIRC116A mutant was measured 
using the CBCA(CO)NH experiment, to define their redox state following expression in BL-21 E.coli 
cells. The chemical shift of the carbon-β atom that is less than 32.5 ppm has previously been defined 
to constitute a reduced cysteine residue (24,25). The chemical shift of six cysteine residues in 
MALTIRC116A were consistent with the reduced state with a chemical shift of less than 32.5 ppm (Table 
3.2). This result is consistent with that observed in the wild-type protein (Section 2.2.12) suggesting 
that the redox state of MALC116ATIR mutant is the same as that of the wild-type protein.  
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Table 3.2 Cysteine carbon-β shifts of MALTIRC116A 
Cysteine residue 
Carbon-β shift 
(ppm) 
Redox state 
(<32.5 ppm = reduced) 
89 28.8 Reduced 
91 28.3 Reduced 
116 - - 
134 29.5 Reduced 
142 31.4 Reduced 
157 25.8 Reduced 
174 28.6 Reduced 
 
3.4.4 NMR solution structure of MALTIRC116A reveals remarkable structural differences from the crystal 
structures 
The lowest energy solution structure of human MALTIRC116A is shown in Figure 3.4 A (PDB 2NDH). The 
top-twenty lowest overall energy structures generated by calculations using TALOS+ for backbone 
dihedral angle restrains (21,22) and CYANA software for torsion angle dynamics calculations (19,20) 
yielded a heavy-atom amide-backbone (NH, Cα, C’) RMSD of 1.28 Å (Table 3.3).   
Typical TIR-domain structures feature a central five-stranded parallel -sheet (strands A–E) 
surrounded by five -helices (A–E) on both sides of the sheet (2). By contrast, the crystal 
structures of MALTIR (5-8) revealed the absence of helix B; the sequence corresponding to strand B 
in typical TIR domain structures is instead located in the long and flexible AB loop. The solution 
structure of the reduced form of MALTIRC116A reveals that the secondary-structure arrangement is 
more consistent with a typical TIR-domain fold than with the crystal structures of MALTIR. The AB 
loop connecting αA and βB is short, comprising only 7 residues (109–115). This loop is followed by 
the strand βB (residues 116–119), as supported by a large number of short to medium-range inter-
residue NOEs (Figure 3.6). This arrangement allows for the formation of a long flexible BB-loop 
between the βB strand and the helix αB; the loop corresponds to residues 120–134, which contain 
many of the unassigned atoms, and where assigned, show few long-range NOEs, suggesting inherent 
flexibility.  
The MALTIRC116A mutant contains six cysteine residues. Consistently with the wild-type protein, the 
chemical shifts of these six cysteine Cβ atoms range from 25.8 to 31.4 ppm, which indicates that all 
cysteine residues are reduced. The solution structure contains one pair of cysteine residues (C142 
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and C174) in close-enough proximity (5.4–6.9 Å) for possible disulfide-bond formation; however, 
chemical shifts of cysteine Cβ atoms indicate that they are both reduced. 
   
    
Figure 3.4 A) NMR solution structure of human MALTIRC116A (PDB ID: 2NDH). B) Top-twenty lowest-
energy models, showing the inherent flexibility of the BB-loop in green.  
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Table 3.3 NMR structure statistics of MALTIRC116A (a) 
 
aAll statistics are given as mean ± SD. 
bOnly structurally relevant restraints, as defined by CYANA, are included.  
cMean r.m.s. deviation calculated over the entire ensemble of 20 structures. 
dAs reported by CYANA (19,20) 
 
 
 
 
 
 
 
 
 
 
Experimental restraints
b
  
 Inter-proton distance restraints  
 Intra-residue  362 
 Sequential 422 
 Medium-range (i–j < 5) 317 
 Long-range (i–j > 5) 262  
 Dihedral-angle restraints 216 
 Total number of restraints per residue 11.12 
RMSD from mean coordinate structure (Å)
c
  
 Backbone atoms (residues 85–120, 134–179 & 204–220) 0.94 ± 0.17 
 All heavy atoms (residues 85–120, 134–179 & 204–220) 1.28 ± 0.14 
Stereochemical quality
d
  
 Residues in most favoured Ramachandran region (%)  78.0 
 Ramachandran outliers (%) 0 ± 0 
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Figure 3.5 Comparison of the solution and crystal structures of MALTIR. Specific regions are coloured 
to highlight the structural re-arrangements between the two structures. (A) Solution structure of 
MALTIR, shown in cartoon representation. (B) Crystal structure of (5) (PDB ID 2Y92). Regions in the 
crystal structure comprising residues 112–123 (AB loop) and 168–171 did not have interpretable 
electron density and were not included in the crystal structure model; they are shown here for 
illustration purposes based on ab-initio modelling and energy-minimisation (5). (C) Structure-based 
sequence alignment, showing the elements of secondary structure. The solution secondary structure 
is based on the calculated structure using CYANA (19,20). ( ) α-helix, ( ) β-strand, (****) loop. 
A  B 
C 
Solution structure of 
MALTIRC116A 
Crystal structure of 
MALTIR 
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Figure 3.6 15N-NOESY strips from MALTIRC116A exhibiting short to medium-ranged NOE cross-peaks 
between residues situated in the βA strand (V88, C89, V90) and the βB strand (A116, F117,L118). 
The residues that participate in hydrogen-bond pairs to form the β-sheet are: V88-A116, C89-F117, 
and V90-L118. The large number of NOEs detected between theses pairs of residues indicates that 
these residues are in close proximity to one another.  
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3.4.5 MALTIR retains its structure at physiological pH 
The chemical shifts of the 15N and 1H atoms from MALTIR were compared after the protein was 
buffered at a pH of 7.5, 8.0 or 8.6. Overall, the chemical shifts remained similar (Figure 3.7), 
suggesting that the structure remains unchanged over the tested pH conditions. An RMSD of 0.017 
ppm was calculated between the spectra at pH 7.5 and 8.6. Residue L120 underwent the largest shift 
when exposed to pH 8.6, with shifts of 0.081 ppm when compared to pH 7.5, while other residues 
underwent minor changes (Appendix Figure 3.8). This change in chemical shift may be due to the 
proximity of the NH of L120 to the aromatic side-chain of the H92 residue, which is susceptible to 
protonation. Exposing the protein to pH 8.0 and 7.5 resulted in a total 9 and 12 new NH resonances, 
respectively, when compared to pH 8.6, consistent with the reduced NH exchange rate at the lower 
pHs.   
 
Figure 3.7 Overlay of 1H-15N-HSQC spectra of MALTIR at pH 7.5, 8.0 and 8.6.  
 
3.4.6 Cysteine reactivity at changing redox conditions 
Exposure of wild-type MALTIR to redox conditions that ranged from fully reducing to fully oxidising, 
with three physiological conditions (26) including -225, -199 and -190 mV, indicated that cysteines 
varied in reactivity. Major changes in chemical shifts were observed at the fully oxidising condition 
containing only GSSG, especially for cysteine residues 89, 91 and 157 (Figure 3.8). Using the 1H-15N-
HSQC experiments that corresponded to the three redox-buffered physiological conditions (-225, -
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199, -190 mV), changes of peak intensity belonging to each cysteine were measured and 
standardised against the highest intensity spectrum (-225 mV) (Figure 3.9). Cysteine residues C116 
and 157 underwent almost no change with around 7% signal change at -190 when compared to -225 
mV, indicating little oxidation of these cysteines at physiological redox potentials. Cysteines 89, 134, 
142 and 174 underwent minor oxidation as indicated by small changes in signal intensities ranging 
from 15-29% at -190 mV compared to -225 mV. By contrast, cysteine residue 91 was the most 
reactive with 45% signal loss at -190 mV, compared to -225 mV, indicating that the major population 
of this residue had been oxidised. 
 
                                      
Figures 3.8 Cysteine residues C89 (A), C91 (B), C116 (C), and 157 (D), showing 1H and 15N shifts 
following exposure to increasingly oxidising conditions.  
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 Figure 3.9 Reactivity of MAL cysteine residues at increasing redox potential.  
 
3.5 Discussion 
Based on the available MAL crystal structures, the construct comprising residues 79–221 (designated 
here MALTIR) was selected for structural studies by solution NMR spectroscopy. The C116A mutant 
(MALTIRC116A) was found to have superior solubility and behaved as a stable monomer, compared 
with the wild-type and other cysteine-to-alanine mutants. The MALTIRC116A structure was found to be 
representative of the wild-type MALTIR based on the comparison of chemical shifts and secondary 
structure prediction. The structure calculations of MALTIRC116A produced an RMSD of 1.28 Å for the 
ensemble of the top 20 lowest energy states using the heavy atoms of the amide backbone (NH, Cα 
and C’). The structure was solved at a pH of 8.6 in a high ionic strength of 200 mM sodium chloride. 
However, the comparison of spectra of 15N-labelled MALTIR in the pH range 8.6–7.5 shows that the 
structure is representative of a more physiological pH. The extreme conditions of high salt and pH 
yielded suitable sample concentrations for NMR analysis. These conditions, however, result in loss of 
signals at rapidly exchanging backbone amide NHs and poor signal-to-noise ratio of the NMR 
resonances. Despite these difficulties, an unconventional data acquisition strategy was used, and 
advanced data acquisition and processing methods at ultra-high fields were used to produce the first 
solution structure of MAL, be it at medium-low resolution.  
Analysis of the amide-backbone chemical shifts (NH, Cα, Cβ and C’) showed a structural re-
arrangement in the protein compared to the crystal structures (Figure 3.5). Consistent with other 
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‘typical’ TIR-domain structures, the solution structure contains a long BB-loop (residues 120–134) 
situated between the strand βB and the helix αB. The BB-loop is a conserved feature among TIR 
domains and a number of studies have identified it to be important for mediating homotypic TIR-
domain interactions (9,11,27,28). The striking structural differences correspond to the secondary 
structure arrangement between residues 111 and 139 (Figure 3.5 C). The crystal structures contain a 
flexible AB-loop corresponding to residues 111–124, linking the helix αA and strand βB. This 
rearrangement is caused by cysteine residues 89 and 134 forming a disulfide bond and shifting the 
location of strand βB. In the solution structure, the Cα atoms of these two cysteine residues are ~11 
Å apart, making disulfide-bond formation unlikely (29). The second disulfide bond found in the 
crystal structures involves the pair C142 and C174. In the solution structure, these residues remain in 
close proximity (~6 Å); however, the chemical shifts of the Cβ atoms from these residues suggest that 
the cysteine side-chains are in a reduced state. In addition, these two cysteine residues are not 
conserved and are  not likely required for the folding of the protein (5). Indeed, chemical shifts of 
the Cβ atoms of all cysteine residues in the solution structure are consistent with a reduced state 
(24).  
MALTIRC116A was purified using an E. coli bacterial expression system. Similarly to mammalian cells, E. 
coli BL-21 cells also contain a reducing cell cytosol (30). The fact that the MALTIRC116A solution 
structure presented here was measured to contain chemical shifts that are consistent with reduced 
cysteine residues is not surprising. Supporting evidence from mass spectrometry using wild-type 
MALTIR determined the presence of a fully reduced species (Section 2.2.6). Given that the 
mammalian cell cytosol is highly reducing, it is most likely that this structure represents the 
physiological state. The redox potential of the mammalian cytosol is fluid and undergoes change 
from about -225 mV to -190 mV, where -225 mV represents the cell proliferation stage and -190 mV 
when the cell is undergoing apoptosis (26). Under fully reducing conditions, there are minor changes 
in the chemical shift of the protein, whereas exposure to the fully oxidised condition results in 
substantial changes (Appendix Figure 3.9). The changes detected are most likely due to variations in 
the redox potential of the buffer condition. As the buffer changes from reducing to oxidising, large 
chemical shifts are detected in the cysteine residues that are likely to be the result of the oxidation 
state of the cysteine. The chemical shifts of cysteine residues in MALTIRC116A measured in the 1H-15N-
HSQC experiment show that they are all reduced at -225 mV. Assessment of cysteine reactivity 
revealed that residue 91 was the most sensitive to oxidation, whereby peak intensity decreased by 
45%, which is attributed to oxidation at a redox potential of -190 mV. In contrast, cysteine 116 was 
the least sensitive with no major changes detected, irrespective of the redox environment. The 
reactivity of C91 demonstrated here could explain the tendency to react with a DTT molecule as 
 
 
66 
 
found in crystal structures. Similarly, peak intensities of cysteine residues C89 and C134 decreased 
by ~28%, suggesting that they underwent oxidation in a -190 mV glutathione buffer. These two 
residues form a disulfide bond in all four crystal structures (5-8). This could explain the formation of 
the disulfide bond observed in the MALTIR crystal structures, and in turn, the structural 
rearrangement of the strand βB. This knock-on effect from this disulfide bond would result in the 
shortening of the BB-loop and the extension of the AB loop.  
Out of the seven cysteine residues in MALTIR, only one (C157) is highly conserved (5). Amongst other 
TIR domains, the position equivalent to cysteine 89 in MAL corresponds to a conserved 
phenylalanine. Considering that the TIR domain fold is conserved, it is highly likely that the disulfide 
bond between residues C89 and C134 in the MALTIR crystal has formed over time required for 
crystallisation and the lack of sufficiently reducing environment. 
Two of the four crystal structures showed the residues C157 and C91 coordinating a DTT molecule 
(5,6). In another crystal structure, these two cysteines were replaced by seleno-methionine (7), 
while a fourth structure showed no interactions with any buffer components (8). Although C157 is 
not as reactive as C91, data presented here shows that the right condition, such as exclusive 
exposure to GSSG, results in a significant chemical shift, indicating oxidation of this residue. In 
addition, mutating the highly conserved C157 residue to an alanine results in a large perturbation of 
the structure, suggesting that this residue is structurally important. Studies have shown that 
mutating residues in the helix αC, on which the conserved C157 resides, results in the inability of 
MAL to immunoprecipitate its binding partner MyD88 (5) and attenuate its ability to signal (6). This, 
together with the ability of C91 and 157 to be modified by glutathionlylation (Section 2.2.7), could 
indicate that these residues are an important pair that could have functional roles in the protein. 
Increasing evidence suggests that during TLR4-mediated immune activation, the cytosolic 
environment becomes more oxidising (31). This can lead to the modification of cysteine residues on 
cytosolic proteins, most commonly to their oxidation by hydrogen peroxide species produced by 
NADPH (32), or by glutathionylation (33). The glutathione S-transferase omega class 1 (GSTO1-1) 
protein has been associated with the glutathionylation of cysteines, resulting in an on/off switch 
(34,35). The precise target protein of GSTO1-1 is unclear; however, there is strong evidence to 
suggest that it regulates proteins early in the TLR4 signalling cascade, which could involve the 
cytosolic TIR domains of TLR4, MAL or MyD88 (36). Taken together with the redox data presented 
here, the identification of redox sensitive cysteines, especially C91, would suggest that 
glutathionylation by GSTO1-1 of these MALTIR cysteines may play an important functional role.   
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Single nucleotide polymorphisms in MAL have a significant impact on the immune response of 
infected individuals. For example, a rare D96N mutation prevents MAL from binding to the 
downstream binding partner MyD88, resulting in no activation of NF-B (37). Lin et al (6) similarly 
demonstrated that mutating residues that reside between R115 and E132 results in decreased NF-B 
activation (6). Put into the context of the solution structure presented here, these mutations are 
located on the βB strand and BB-loop. This work has striking implications because these regions 
differ remarkably between the solution and crystal structures. The NMR solution model therefore 
provides a new framework for future work on the effects of mutations and modelling studies. 
 
3.6 Conclusions 
Results presented here show the solution structure of MALTIRC116A in the reduced form, as 
determined by NMR spectroscopy. The structure shows striking differences to the crystal structures 
of MALTIR determined previously (5-8), which represent the oxidised form of the protein. Three of 
the seven cysteine residues in the reduced form are sensitive to redox change when exposed to 
oxidising conditions, for example through the addition of GSSG. The work suggests that the cysteines 
91 and 157 could play an important role in the signalling and regulation involving the mammalian 
MAL adaptor protein. The crystal structure of MALTIR has been used in a number of attempts to 
model the interactions involving this adaptor during signalling (12,38-40). The structure presented 
here suggests that the crystal structure may not be the signalling-competent form. This new 
structure now provides a better template for modelling approaches. 
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3.7 Chapter 3 appendix 
Comparison of chemical shifts between the cysteine mutants and the wild-type protein (Appendix 
Figures 3.1–3.7) 
1H and 15N chemical shifts of residues from the MALTIR mutants are compared to the wild-type 
protein. An arbitrary threshold of 0.2 ppm is selected as a significant chemical shift change between 
the mutants and the wild-type protein and is indicated by a dashed line.  
 
Appendix Figure 3.1 Comparison of chemical shifts between the C89A mutant and the wild-type 
MALTIR protein. 
 
 
Appendix Figure 3.2 Comparison of chemical shifts between C91A mutant and the wild-type MALTIR 
protein. 
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Appendix Figure 3.3 Comparison of chemical shifts between C116A mutant and the wild-type MALTIR 
protein. 
 
 
Appendix Figure 3.4 Comparison of chemical shifts between C134A mutant and the wild-type MALTIR 
protein. 
 
 
Appendix Figure 3.5 Comparison of chemical shifts between C142A mutant and the wild-type MALTIR 
protein. 
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Appendix Figure 3.6 Comparison of chemical shifts between C157A mutant and the wild-type MALTIR 
protein. 
 
 
Appendix Figure 3.7 Comparison of chemical shifts between C174A mutant and the wild-type MALTIR 
protein. 
 
 Appendix Figure 3.8 Comparison of chemical shifts for MALTIR at pH 7.5 and 8.6. 
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Appendix Figure 3.9 RMSD comparison of 1H and 15N chemical shifts between different redox 
conditions. 
Condition GSH only 
-225 mV 0.019 
-199 mV 0.019 
-190 mV 0.018 
GSSG only 0.049 
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Chapter 4 
Solution structure of Sr33 using NMR spectroscopy 
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4.1 Contribution 
Chapter 4 includes the manuscript titled “The solution structure of Sr33 challenges paradigms for 
coiled-coil domain dimerization in plant NMR immune receptors,” which will be submitted 
imminently for publication. This piece of work has involved a large collaboration between 
researchers with skills spanning structural biology, biophysics and plant biology techniques. My role 
in this work includes:  
 
 The expression and purification of the 15N and 13C labelled constructs and preparation of this 
protein for NMR spectroscopy 
 Assignment of 1H, 15N and 13C resonances to the atoms of Sr336-120 
 Refinement of the Sr336-120 structure 
 Writing of the NMR sections of the paper and figure preparation 
 Drafting of the entire paper in combination with other authors of the manuscript 
The NMR structure of Sr336-120 was a very important outcome for the full biophysical, structural and 
functional studies. This is recognised by my joint-first author position on the manuscript.    
 
4.2 Preface 
One research focus in the Kobe laboratory is the structural characterisation of plant NLR (nucleotide-
binding oligomerization domain (NOD)-like receptor) proteins. Plant NLRs are important innate 
immunity receptors capable of detecting molecules from plant pathogens, which the pathogen 
utilises during invasion, to initiate defence pathways. During my PhD candidature, an opportunity 
arose to be a part of a large collaboration that would focus on understanding the signalling function 
of the N-terminal coiled-coil (CC) domain from the agriculturally important wheat stem-rust 
resistance NLR, Sr33. Plant NLR proteins generally contain either a CC or TIR domain at their N-
terminus and both have been implicated in defence signalling through homotypic interactions. 
Currently in the literature, there are two published crystal structures of CC domains from NLR 
proteins, namely: barley MLA10, which is responsible for resistance to barley powdery mildew; and 
potato Rx, responsible for resistance to potato virus X. The crystal structures of the CC domains from 
the two proteins are significantly different. The structure of MLA10 revealed an antiparallel 
homodimer adopting a helix-loop-helix fold, while the structure of Rx revealed a compact 
monomeric four-helical bundle. This data suggested that the CC domains of plant NLRs are 
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structurally diverse, which could have implications for the function of this domain in defence 
signalling.  
Sr33 is an ortholog of MLA10 and the CC domains share a high sequence identity (~82%). Both Sr33 
and MLA10 only share limited similarity with the distantly related Rx (~18%). Multi-angle laser light 
scattering (MALS) experiments performed in our laboratory indicated that the CC domains from all 
three proteins, MLA10, Sr33 and Rx, were monomeric in solution, which was not consistent with the 
reported crystal structure and biochemical data for MLA10 (12). This initiated a structural and 
biophysical study of Sr33, which included x-ray crystallography, small-angled x-ray scattering and 
NMR, where I made my key contribution. I determined the NMR structure of Sr33 CC domain, which 
revealed that the structure of Sr33 CC domain has a fold similar to that of Rx, adopting a compact 
four-helix bundle. This is strikingly different to the structure of the more closely related MLA10. In 
addition, this NMR study, with support from other biophysical studies detailed in the manuscript 
below, has shown that Sr33 is monomeric and has little propensity to self-associate in vitro. This 
work has then led to the determination of a minimal functional unit of an NLR coiled-coil domain, 
which is ~20 amino acids longer than the previously presented structures and the Sr33 structure 
presented here. This has revealed that in planta, these longer CC domains self-associate and act as a 
switch that result in a defence activation, represented by an apoptotic-like cell death response. The 
structural discovery of Sr33 presented here suggests that distant and closely related CC domains are 
structurally conserved and have reconciled previous conflicting structural data.  
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The solution structure of Sr33 challenges paradigms for coiled-coil domain 
dimerization in plant NLR immune receptors 
Lachlan W. Casey1*, Peter Lavrencic1,5*, Adam Bentham1,2*, Stella Cesari3, Daniel Ericsson4, Peter A. 
Anderson2, Alan E. Mark1, Peter N. Dodds3, Mehdi Mobli5§, Bostjan Kobe1§  and Simon J. Williams1,2,6§ 
 
1School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian 
Infectious Diseases Research Centre, University of Queensland, Brisbane, Queensland 4072, 
Australia. 2School of Biological Sciences, Flinders University, Adelaide, SA 5001, Australia. 3CSIRO 
Agriculture Flagship, GPO Box 1600, Canberra ACT 2601, Australia 4MX Beamlines, Australian 
Synchrotron, 800 Blackburn Road, Clayton, Victoria 3168, Australia. 5Centre for Advanced Imaging, 
University of Queensland, Brisbane, Queensland 4072, Australia. 6Plant Sciences Division, Research 
School of Biology, The Australian National University, Canberra 2601, Australia 
* These authors contributed equally to this work 
§Corresponding authors: s.williams8@uq.edu.au (+61733469073), b.kobe@uq.edu.au 
(+61733652132), m.mobli@uq.edu.au (+617334 60352) 
Classification: BIOLOGICAL SCIENCES, Biophysics 
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oligomerization domain (NOD)-like receptor (NLR), nuclear magnetic resonance (NMR), small-angle 
X-ray scattering (SAXS), multi-angle laser light scattering (MALS), X-ray crystallography. 
 
4.3 Abstract 
Plant NLRs (nucleotide-binding oligomerization domain (NOD)-like receptors) recognize specific 
pathogen effector proteins and initiate immune responses. Their multi-domain architecture 
comprises a central nucleotide-binding domain, a C-terminal leucine-rich repeat domain and either 
CC (coiled-coil) or TIR (Toll/interleukin-1 receptor/resistance) domain at the N-terminus. The CC and 
TIR domains are involved in defence signalling and have been implicated in homotypic interactions. 
Here, we present the solution structure of the coiled-coil fragment from the wheat stem-rust NLR 
protein Sr33 comprising residues 6–120. The domain adopts a four-helix bundle conformation that 
unexpectedly differs significantly from the published crystal structure of the CC domain from the 
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orthologous barley powdery mildew resistance protein, MLA10, which forms a homo-dimer. 
However, the structure of Sr33 is similar to the distantly related CC domain from the potato NLR 
protein Rx. Biophysical studies demonstrate that the analogous regions of Sr33, MLA10 and Rx are 
monomeric and adopt similar folds in solution. However, we found that larger N-terminal fragments 
of Sr33 and MLA10 (up to 160 amino acids) can homo-dimerise in solution and co-
immunoprecipitate when expressed in planta, and this self-association property correlates with their 
ability to signal cell death in planta. We define the minimal functional signalling region of the CC 
domain in these proteins as comprising amino acids 1–142. This includes an additional 22 amino 
acids predicted to form an -helix that is absent from the crystal and solution structures and is 
required for both dimerization and signalling. The correlation between signalling and self-association 
suggest that collectively, our study contributes new insights into our structural and functional 
understanding of the CC domains from plant NLR proteins.  
 
4.4 Introduction 
Plant diseases constitute a major economic and social burden worldwide, and the appearance of 
new or resistant pathogens can pose significant challenges. Plants rely on their innate immune 
systems to combat emerging pathogens. An important component of plant innate immunity is the 
recognition of pathogen effector molecules by resistance (R) proteins within the plant cell. R protein 
activation triggers a process known as the hypersensitive response (HR), which often culminates in 
localized cell death at the site of infection, leading to general immunity of the whole plant (1,2). 
One such resistance protein is encoded by the recently discovered wheat gene Sr33 (3). Sr33 confers 
resistance to the virulent Ug99 strain of wheat stem rust, Puccinia graminis f. sp. tritici (Pgt), a 
pathogen well recognized for its potential threat to global food security. As a member of the 
canonical class of plant R genes, Sr33 encodes a large (~110 kDa) multi-domain protein consisting of 
a central nucleotide-binding (NB) domain, a C-terminal leucine-rich repeat (LRR) domain and an N-
terminal coiled-coil (CC) domain (3). These proteins have a similar domain arrangement and function 
to the nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) from mammals, and 
are commonly referred to as plant NLRs.  
While the molecular detail of plant NLR activation and signalling is not fully understood, targeted 
studies have helped define the roles of their different domains. The central NB domain appears to 
control the activation of the protein through nucleotide binding and exchange (4-6). The LRR domain 
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plays a role in effector recognition specificity for a number of plant NLRs, and in some cases it is 
implicated in effector binding (7,8). The LRR domain also appears to have a general autoinhibitory 
role and structural and biochemical studies of the human NLR proteins NAIP and NLRC4 support this 
conclusion (9). In plant NLRs, the N-terminal domain consists of either a CC (coiled-coil) domain, as in 
Sr33, or a TIR (Toll/interleukin-1 receptor/resistance protein) domain. Both CC and TIR domains are 
implicated in downstream signalling, and have been shown to be necessary and sufficient for HR 
responses in a number of systems (10-16).  
Oligomerization has long been implicated in animal NLR protein activation and function and this 
process has been recently observed structurally for the activated inflammasome formed by the 
animal NLR proteins, NAIP2/NLRC4 (17-19). Our understanding of these processes in plant NLRs is 
much more limited. To date, effector-induced self-association of a full-length plant NLR has been 
demonstrated only for the tobacco mosaic virus resistance protein, N (20). Structure-guided studies 
restricted to the N-terminal TIR or CC domains have expanded upon this, demonstrating that weakly 
associating, transient self-interactions are necessary for signalling by the TIR domains of the plant 
NLRs L6 and RPS4 (11,15). Furthermore, strong heterodimeric interactions between the TIR domains 
of RPS4/RRS1 appear to negatively regulate this dual-resistance protein complex (15).  
Even less is known about oligomerization of the CC domain-containing plant NLRs like Sr33. While 
the plant NLR TIR domains have a conserved fold (11,15), the structures of two (partial) CC domains 
are strikingly different. The N-terminal amino-acids 5–120 of barley powdery mildew A 10 (MLA10) 
crystallized as an antiparallel homodimer adopting a helix-loop-helix fold (12). The structure appears 
to form an obligate dimer. This suggested that dimerization is required for activation, although this 
has not been established experimentally. The second structure, the CC domain of potato Rx, was 
seen to adopt a compact four-helical bundle in a 1:1 hetero-association with the RanGAP2 co-factor 
(21), clearly distinct from the MLA10 homodimer. Moreover, the Rx CC was stable as a monomer 
without its cofactor in vitro. Together, these studies suggested that significant structural and 
mechanistic variation may be present among the CC domains of plant NLRs. 
To understand the role of CC domains in NLR protein signalling further, we investigated the wheat 
stem-rust NLR protein Sr33. Here, we present the three-dimensional (3D) solution structure of Sr33 
CC domain (residues 6–120; Sr336-120), determined by nuclear magnetic resonance (NMR) 
spectroscopy. Despite being an ortholog of MLA10 and having high sequence identity (~82%) across 
this region, our structure looks much more similar to the CC domain (residues 1–122) of Rx (Rx1-122; 
~18% identity). Subsequently, we carried out a detailed biophysical comparison of the CC domains of 
Sr33, MLA10 and Rx. These studies suggest that the CC-NLRs may not be as disparate as previously 
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thought. We show that the regions responsible for self-association are beyond the domain 
boundaries set by current structural data and in doing so, we define the minimal functional region of 
plant CC domains. 
 
4.5 Methods 
4.5.1 Cloning, expression and purification 
The cDNAs coding for the proteins under study were cloned into the pMCSG7 vector by ligation-
independent cloning (22). For biophysical studies, the proteins were expressed in Escherichia coli 
BL21 (DE3) using the autoinduction method (23). Cells were lysed via sonication in the lysis buffer 
(consisting of 50 mM HEPES pH 8.0, 300 mM NaCl and 1 mM dithiothreitol (DTT)) for Sr336-120, 
MLA105-120 and Rx1-122. A similar lysis buffer was used for the longer CC domain fragments 
(corresponding to Sr336-144, Sr336-160, MLA105-144 and MLA105-160); however, the pH was adjusted to 
7.5 and 500 mM of NaCl was used. The proteins were separated from clarified cell lysate via 
immobilized metal affinity chromatography (IMAC), facilitated by N-terminal 6 x histidine tags. 
Overnight treatment with TEV (tobacco etch virus) protease was used to remove the histidine tag, 
leaving a three-residue N-terminal overhang (Ser-Asp-Ala). The theoretical molecular weights for 
Sr336-120, MLA105-120 and Rx1-122 are therefore 13.1, 13.4 and 14.2 kDa, respectively. The cleaved 
protein was reapplied to the nickel affinity chromatography column to remove the TEV protease and 
other contaminants. The proteins were further purified using a Superdex 75 HiLoad 26/60 size-
exclusion chromatography column [GE Healthcare] equilibrated with 10 mM HEPES pH 8.0, 150 mM 
NaCl and 1 mM DTT. 
 
4.5.2 Protein expression for NMR spectroscopy 
E. coli BL21 cells expressing the Sr336-120 protein (see above) were grown in M9 minimal media 
containing 13C-labelled glucose,  and 15N-labelled ammonium chloride. Protein expression was 
induced using 1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) at 20˚C for overnight protein 
expression. The 13C/15N-labelled Sr336-120 protein was purified using nickel affinity and size-exclusion 
chromatography as described above.  
The correlation time of the protein was estimated based on transverse relaxation rates (T2), 
measured as described previously (24). The correlation time was converted to a molecular weight 
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using the Stoke-Einstein equations (25), using a modified equation for estimation of protein volumes 
(26)  with the addition of 2 Å to account for the hydration shell.  
 
4.5.3 NMR data acquisition 
The 13C/15N-labelled Sr336-120 sample containing 5% D2O was filtered using a low-protein-binding 
Ultrafree-MC centrifugal filter (0.22 µm pore size; Millipore, MA, USA), then 300 L was added to a 
susceptibility-matched 5 mm outer-diameter microtube [Shigemi Inc., Japan]. 
NMR data were acquired at 25˚C using a 900 MHz AVANCE spectrometer [Bruker BioSpin, Germany] 
equipped with a cryogenically cooled probe. Data used for resonance assignment were acquired 
using non-uniform sampling (NUS); sampling schedules that approximated the rate of signal decay 
along the various indirect dimensions were generated using sched3D (27). The decay rates used 
were 1 Hz for all constant-time 15N dimensions, 30 Hz for all 13C dimensions, and 15 Hz for the semi-
constant indirect 1H dimension. 13C- and 15N-edited HSQC-NOESY experiments were acquired using 
linear sampling. Separate experiments were acquired for the aliphatic and aromatic regions of the 
13C dimension. 
NUS data were processed using the Rowland NMR toolkit (www.rowland.org/rnmrtk/toolkit.html); 
maximum entropy parameters were selected automatically as described previously (28,29). NMR 
spectra were analyzed and assigned using the program CcpNmr (30). 1HN, 
15N, 13C backbone 
resonance assignments were obtained from the analysis of amide-proton strips in 3D HNCACB, 
CBCA(CO)NH, and HNCO spectra. Sidechain 1H and 13C chemical shifts were obtained primarily from 
3D H(CC)(CO)NH-TOCSY and (H)CC(CO)NH-TOCSY spectra, respectively. The remaining side-chain 
assignments were derived from 3D H(C)CH-TOCSY and 15N- and 13C-edited NOESY-HSQC spectra. 
 
4.5.4 NMR structure determination 
Distance restraints for structure calculations were derived from 3D 13C- and 15N-edited NOESY-HSQC 
spectra acquired with a mixing time of 120 ms. NOESY spectra were manually peak-picked and 
integrated using the box-sum method in CcpNMR (31). The peak lists were then assigned and an 
ensemble of structures calculated automatically using the torsion angle dynamics package CYANA 
(31,32). The tolerances used in the structure calculations were 0.03 ppm in the indirect 1H 
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dimension, 0.02 ppm in the direct 1H dimension, 0.2 ppm for the aromatic 13C and 15N dimensions, 
and 0.4 ppm for the aliphatic 13C data.  
Backbone dihedral-angle restraints (112 restraints each for  and ) were derived from TALOS+ 
chemical shift analysis (33); the restraint range was set to twice the estimated standard deviation. 
All X-Pro peptide bonds were clearly identified as trans on the basis of characteristic C and Cγ 
chemical shifts for the Pro residues. 
CYANA was used to calculate 200 structures from random starting conformations, then the 20 
conformers with the lowest CYANA target function were chosen to represent the structural 
ensemble. During the automated NOESY assignment/structure calculation process CYANA assigned 
94.4% of all NOESY crosspeaks (3186 out of 3372) for Sr33.  
 
4.5.5 Size-exclusion chromatography (SEC)-coupled multi-angle light scattering (MALS) 
SEC-MALS was performed using an in-line Superdex 200 100/300 GL or Superdex 200 Increase 5/150 
GL SEC column [GE Healthcare] combined with a Dawn Heleos II 18-angle light-scattering detector 
coupled with an Optilab TrEX refractive index detector [Wyatt Technology, Santa Barbara, CA, USA]. 
Purified proteins were separated at 0.5 mL/min (10/300) or 0.25 mL/min (5/150) in 10 mM HEPES pH 
8.0 and 150 mM NaCl. Molecular-mass calculations were performed using the Astra6.1 software 
[Wyatt Technology]. Input of the refractive increment (dn/dc values) was set at 0.186 in the 
molecular-mass calculations, based on the premise that dn/dc is constant for unmodified proteins 
(52). The molecular mass was determined across the protein elution peak. 
 
4.5.6 Analytical size-exclusion chromatography (SEC) and cross-linking 
The purified MLA105-120 protein (450 g) was separated on a Superdex 75 10/300 GL SEC column 
with a mobile phase consisting of 10 mM HEPES pH 7.5 and 150 mM NaCl (SEC buffer). Protein size 
markers chymotrypsin (25 kDa) and cytochrome c (15 kDa) were separated using the same 
conditions as for MLA105-120. Cross-linking experiments were performed as previously described (12). 
In brief, 20 L of MLA105-120 (in the SEC buffer) at a concentration of 150 M was mixed with 5 L of 
BS3 (bis(sulfosuccinimidyl)suberate) at a concentration of 20 mM. The reaction was incubated on ice 
and monitored at various time points from 0-120 minutes. The reaction was quenched with equal 
volumes of 1 M Tris pH 7.5, before the samples were separated using 13% SDS-PAGE. 
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4.5.7 Size-exclusion chromatography (SEC)-coupled small-angle X-ray scattering (SAXS) 
SEC-SAXS was performed during two shifts at the SAXS/WAXS beamline of the Australian 
Synchrotron on a Pilatus 1M detector, using an in-line WTC-030S5 SEC column and a 2 mL WTC-
030S5G pre-column [Wyatt Technology], together with a Prominence modular HPLC system 
[Shimadzu Scientific Instruments]. All experiments were conducted at 16°C using 10 mM HEPES (pH 
7.5), 150 mM NaCl buffer with 1 mM DTT. For data collection, eluate from the column was directed 
through a 1 mm quartz capillary mounted in the beam. For all samples, the injected volume was 95 μL 
at 30 mg/mL protein concentration, as determined by UV absorbance at 280 nm. High concentrations 
were used to maximize signal after dilution during gel-filtration.  
The data for Sr33 was collected in 5 s exposures at 0.05 s intervals with a flow rate of 0.2 mL/min. A 
Wyatt WTC-030S5G pre-column was used upstream of the WTC-030S5.  The sample-to-detector 
distance was 1.6 m, and a wavelength of 1.12713 Å yielded a range of momentum transfer         
(0.009 < q < 0.478 Å-1, where q = 4π.sin(θ)/λ). The data for MLA105-120 and Rx1-122 were collected       
on the same column at a different time, in 2 s exposures at 0.05 s intervals, with sample            
flowing at a rate of 0.5 mL/min. The pre-column was not used for these samples. In                                         
this case, a sample-to-detector distance of 1.4 m was used to obtain data over the range                                                                       
0.010 < q < 0.614 Å-1. Data reduction and subtraction was performed using scatterBrain 
(http://www.synchrotron.org.au/index.php/aussyncbeamlines/saxswaxs/software-saxswaxs). Unless 
noted otherwise, subsequent analyses were performed using the tools in version 2.6 of the ATSAS 
program suite (34).  
100 frames immediately preceding each peak were summed and normalized for exposure time to 
obtain buffer blanks. Initially, these buffers were subtracted from each individual image to generate a 
series of subtracted frames across the elution peak, in order to evaluate the evolution of calculated 
properties. To this end, I(0) and Rg were calculated for each frame using the Guinier approximation, as 
implemented in batch-mode AUTORG, for points such that q.Rg <1.3. Molecular weights were 
calculated using the volume of correlation (Vc) (35). 
These metrics were evaluated for variation across the peak. To obtain the final scattering curves for 
analysis, the original images, from peak regions over which Rg and MWVc remained stable, were 
summed and normalized in scatterBrain, and then subtracted from the corresponding blank.  
Guinier analysis and the determination of I(0), Rg and MWVc were performed on the summed and 
averaged curves in the same manner as for individual frames, but using AUTORG in Primus instead of 
in batch (36). Data-points closer to the beamstop than the first selected Guinier point were 
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discarded. Points where q > 0.46 Å-1 were also discarded, due to poor signal-to-noise. Distance 
distributions, P(r), were then obtained by indirect transformation in GNOM (37), informed by 
AUTOGNOM. In addition to MWVc, molecular weights were also estimated from the Porod volume 
calculated by GNOM. In this estimation, the protein density was assumed to take the canonical value 
of 1.37 g cm-1 (38). 
Theoretical scattering was calculated from atomic models using FoXS (39). Short stretches of 
residues not visible in the electron density of the published MLA105-120 crystal structure were added 
to both chains using the loop-building routines in MODELLER (40,41) independently from the SAXS 
data.  
 
4.5.8 Crystallization and crystal structure determination of MLA105-120 
Native and selenomethionine-labelled MLA105-120 protein at 10 mg/mL and 6 mg/mL, respectively, in 
10 mM HEPES (pH 8.0), 100 mM NaCl, and 1 mM DTT were used in crystallization trials. 
Crystallization experiments were initially performed with native protein using hanging-drop vapour 
diffusion in 96-well plates. Several commercial screens were used, including Index, PEG/Ion and 
PEGRx [Hampton Research] and Pact Premier and JCSG+ [Molecular Dimensions]. 100 nl protein 
solution and 100 nl well solution were prepared on hanging-drop seals [TTP4150-5100 sourced from 
Millennium Science, Australia] using a Mosquito robot [TTP Lab- Tech, UK] and equilibrated against 
75 ml reservoir solution. The drops were monitored and imaged using the Rock Imager system 
[Formulatrix, USA]. Numerous promising hits were observed within 24 hours; however, the crystals 
grown in Pact Premier, condition B4 (MIB buffer pH 7.0 (42), 25% PEG 1500) were pursued for data 
collection. Crystals grown in larger 1:1 L (protein: well solution) drops were cryo-protected using 
the well-solution containing 20% glycerol prior to flash-cooling in liquid nitrogen. X-ray diffraction 
data of native crystals were collected from a single crystal at the Australian Synchrotron MX1 
beamline to ~2.0 Å resolution using a wavelength of 0.9537 Å. The crystal-to-detector distance was 
set to 200 mm and the oscillation range was 0.5°. Data collection was performed using Blu-Ice 
software (43), indexed and integrated using XDS (44) and scaled with AIMLESS within the CCP4 suite 
(45). With the native dataset molecular replacement was attempted using the published MLA105-120 
structure (PDB ID 3QFL;(12)) in monomeric, dimeric and various truncated forms, as well as the 
structure of Rx1-122 (PDB ID 4M70; (21)); however, a solution could not be obtained. Subsequently, 
selenomethionine-labelled protein (confirmed by mass spectrometry, data not shown) was 
crystallized as described for the native protein. X-ray diffraction data of selenomethionine-labelled 
crystals were collected from a single crystal at the Australian Synchrotron MX2 beamline to ~2.1 Å 
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resolution using a wavelength 0.9792 Å. The crystal-to-detector distance was set to 200 mm and the 
oscillation range was 0.5°. Data collection was performed using Blu-Ice software (43), indexed and 
integrated using XDS (44), and scaled with AIMLESS within the CCP4 suite (45). 
The crystals of MLA105-120 appeared to have symmetry of space group P2 21 21 and the structure 
was solved using single-wavelength anomalous diffraction (SAD) through the CRANK2 pipeline (46). 
Due to issues during refinement in the P2 21 21 space group, we performed further refinement in 
P1. Statistics for the refined atomic model are presented in Appendix Table 4.3. 
 
4.5.9 Constructs for in planta analyses 
For transient expression in N. benthamiana, molecular cloning was performed by a combination of 
Quikchange site-directed mutagenesis [Agilent Technologies] and Gateway recombination [Life 
Technologies]. The MLA101-160, Sr331-160 and Sr501-163 constructs cloned in pDONR207 (29) were used 
as templates for site-directed deletion to generate the MLA101-130, MLA101-135, MLA101-141, MLA101-
142, MLA101-144, MLA101-148, Sr331-130, Sr331-135, Sr331-141, Sr331-142, Sr331-144, Sr331-148, Sr501-133, Sr50
1-
138, Sr501-144, Sr501-145, Sr501-147 and Sr501-151  ENTRY constructs. These constructs were then 
recombined by LR reaction in the binary vector pBIN19-35S::GTW:3HA or pBIN19-35S::GTW:CFP by 
LR coning to obtain expression vectors.  
 
4.5.10 Transient protein expression and cell death assays in N. benthamiana  
N. benthamiana plants were grown in a growth chamber at 23°C with a 16 hours light period. For N. 
benthamiana leaf transformations, pBIN19-derived vector constructs were transformed into 
Agrobacterium tumefaciens strain GV3101_pMP90. Bacterial strains were grown in Luria-Bertani 
liquid medium containing 50 mg/ml rifampicin, 15 mg/ml gentamycin and 25 mg/ml kanamycin at 
28°C for 24 hours. Bacteria were harvested by centrifugation, resuspended in infiltration medium   
(10 mM MES pH 5.6, 10 mM MgCl2 and 150 µM acetosyringone) to an OD600 nm ranging from 0.5 
to 1, and incubated for 2 hours at room temperature before leaf infiltration. Three leaves from two 
plants were infiltrated for each combination of constructs and the experiment was repeated three 
times independently. The infiltrated plants were incubated in growth chambers under controlled 
conditions for all following assays. For documentation of cell death, leaves were scanned five days 
after infiltration. 
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4.5.11 Protein extraction Western blot and co-immunoprecipitation 
Protein extraction from N. benthamiana leaves and co-IP experiments were performed as described 
(49). For immunoblotting analysis, proteins were separated by SDS-PAGE and transferred to a 
nitrocellulose membrane. Membranes were blocked in 5% skimmed milk and probed with anti-HA-
HRP antibodies [Roche] or anti-GFP antibodies [Roche] followed by goat anti-mouse antibodies 
conjugated with horseradish peroxidase [Pierce]. Labeling was detected using the SuperSignal West 
Femto chemiluminescence kit [Pierce]. Membranes were stained with Ponceau S to confirm equal 
loading. 
 
4.6 Results 
4.6.1 The NMR structure of Sr336-120 reveals a compact four-helical bundle 
Previous structural studies of the Sr33 ortholog MLA10 encompassed residues 5–120 of the CC 
domain (MLA105-120). For our investigation, we initially focussed on an equivalent region within the 
Sr33 CC domain. Soluble Sr33 CC domain protein was produced by recombinant expression of a 
construct comprising residues 6–120 (hereafter referred to as Sr336-120) in Escherichia coli. The E. coli 
cells were grown in M9 minimal media and labelled selectively with 15N and 13C. The labelled protein 
was purified to homogeneity using metal-affinity chromatography, followed by size-exclusion 
chromatography (SEC). The atomic structure of Sr336-120 was determined by NMR spectroscopy.  
Sr336-120 is monomeric in the buffer used for structural studies, according to average T2 relaxation 
rates of the backbone amides  (yielding the correlation time of ~8.7 ns,  consistent with a calculated 
molecular weight ~13 kDa;  the theoretical molecular weight of Sr336-120 is 13.1 kDa (24)). This is also 
evident in the sharp line-widths of the resonances, which are consistent with a monomeric and not a 
dimeric form of Sr336-120. 
Analysis of the assigned chemical shifts (47) revealed four distinctive α-helical regions (α1, residues 
7–19; α2, 28–51; α3, 60–87; and α4; 99–115). Other than the termini, two small regions (comprising 
residues 22–23 and 88–91) were found to have near random-coil chemical shifts, indicating that 
these regions are highly dynamic. The residues corresponding to 88–91 in MLA105-120 are poorly 
defined in the crystal structure as well; however, the residues corresponding to 22–23 in MLA105-120 
appear in an ordered helical region (see below). 
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Dihedral angles derived from the chemical shift analysis were used together with distance restraints 
from 15N and 13C edited NOESY experiments to calculate a 3D structure of the protein. The structure 
shows that the protein is predominantly α-helical, folded in a four-helix bundle (Figures 4.1A and 
S4.2). The 20 lowest energy structures show an RMSD (root-mean-square-distance) for the amide 
backbone atoms (N, Cα, and C’) of residues 6–89, 98–110 of 0.93 Å (Appendix Table 4.1). 
Previous studies have indicated that the EDVID motif is conserved among CC domains and is 
important in mediating intramolecular interactions (21,48). In Sr336-120, the equivalent motif 
(residues 77–81) encodes residues EDAVD, which reside in the α3 helix with residues E77, D78, V80 
and D81 all surface-exposed (Figure 4.1A). Despite the higher sequence similarity between Sr336-120 
and MLA105-120, the solution structure of Sr336-120 resembles the structure of Rx1-122 more closely 
(Figure 4.1 B–E). 
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Figure 4.1 The solution structure of Sr33 reveals a four-helix bundle fold. (A) NMR structure of      
Sr336-120 in cartoon representation, with the individual helices and N- and C-termini labelled. The 
conserved EDVID motif (EDAVD in Sr33), is shown in stick representation. (B) Superposition of the 
Sr336-120 structure (blue) and the crystal structure of MLA105-120 (yellow) in cartoon representation. 
Missing residues in MLA105-120 structure (amino acids 91–95) are shown by a dotted line. Green 
colouring represents the position of the EDVID motif. The crystallographic dimer observed for 
MLA105-120 is shown as a black-and-white outline. (C) Superposition, as shown in B, rotated 90° 
around the y-axis. (D) Superposition of the Sr336-120 structure (blue) and the crystal structure of     
Rx1-122 (red) in cartoon representation. Missing residues in Rx1-122 structure (amino acids 40–50) are 
shown by a dotted line. Green colouring represents the position of the conserved EDVID motif. 
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4.6.2 Biophysical characterization shows that Sr336-120, MLA105-120 and Rx1-122 are predominantly 
monomeric in solution 
In light of the NMR results suggesting that Sr336-120 behaves as a monomer, we employed additional 
in vitro biophysical techniques to interrogate this further. We also produced and analyzed the 
MLA105-120 and Rx1-122 constructs used for structure determination previously (12,21). SEC-coupled 
multi-angle light scattering (SEC-MALS) experiments performed on the three CC-domain proteins 
confirmed that Sr336-120 and Rx1-122 were monomeric in solution, even at loading concentrations of 
30 mg/mL (Figures 4.2A–C). Unexpectedly, this was also true of MLA105-120. The average MALS-
derived molecular weights were 13.7 kDa for Sr336-120, 13.3 kDa for MLA105-120, and 13.3 kDa for   
Rx1-122, while the predicted monomeric molecular weights from these constructs are 13.1 kDa, 13.4 
kDa and 14.3 kDa, respectively.  
We examined the oligomeric states further using in-line SEC-coupled small-angle X-ray scattering 
(SEC-SAXS), which revealed some variation that was not apparent by SEC-MALS (Figures 4.2D–F). The 
SAXS-derived molecular weight of Sr336-120 varied between 12.5 and 13.8 kDa across the peak, with a 
trend towards smaller particles at the elution tail. This variation was more pronounced for both 
MLA105-120 and Rx1-122, with the calculated molecular weights increasing from ~13 at the start of the 
peak to ~16 kDa at the peak centre, and then decreasing again to 12 kDa at the tail; this variation 
was accompanied by the corresponding changes in the radii of gyration (Rg). This trend suggests a 
concentration-dependent post-elution effect, but it is unclear whether this is due to self-association 
or non-specific aggregation. Averaged peak-centre and peak-tail datasets for each protein 
demonstrate this shift to larger particles across the elution profile (Appendix Figure 4.2), and the 
corresponding calculated properties are reported in Appendix Table 4.2.  
These results differ from the observations made previously by Maekawa et al (12), who, in addition 
to the crystal structure, presented in vitro data from analytical SEC which suggested the MLA105-120 
protein behaved as a dimer in solution. To ensure the two sets of recombinant samples were 
consistent, we repeated these experiments on our own purified MLA105-120 protein. We found that 
our MLA105-120 does indeed elute at a volume similar to the 25 kDa chymotrypsin marker during SEC 
(Appendix Figure 4.3). This was also the case for Sr33 and Rx, and the discrepancy with the MALS 
data suggests that the elution time is influenced by protein properties other than size (Appendix 
Figure 4.3).  
Our data shows that Sr336-120 does not exhibit detectable self-association in vitro at the 
concentrations tested. Some limited self-association was observed for MLA105-120 and Rx1-122 during 
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SEC-SAXS at high protein concentration, but this was not apparent by SEC-MALS. The data agrees 
that the predominant species for both proteins is monomeric.  
 
Figure 4.2 Sr336-120, MLA105-120 and Rx1-122 are largely monomeric in solution. (A–C) Molecular weight 
calculations based on SEC-MALS analysis for Sr336-120 (A, B), MLA105-120 (C, D) and Rx1-122 (E, F). For all 
proteins, the solid black lines represent the normalized refractive index trace (arbitrary units, y-axis) 
for proteins eluted from an in-line Superdex 200 10/300 column [GE]. Coloured lines under the 
peaks correspond to the averaged molecular weight (MW; right-hand y-axis) distributions across the 
peak as determined by MALS. (A, C, E) Evolution of particle Rg and molecular weight during in-line 
SEC-SAXS with a WTC-030S5 column, for Sr335-120 (B), MLA105-120 (D) and Rx1-122 (F). For all proteins, 
the trace of zero-angle intensity, I(0), is plotted as a black line, whereas both Rg and MWVC are 
plotted as coloured lines against the right-hand y-axis. Rg is shown with experimental errors at 1σ in 
lighter colours. The predicted molecular weight of each construct is shown as black dotted lines. The 
use of a 2 mL pre-column for Sr336-120 shifts that peak by the corresponding volume. 
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4.6.3 Crystal structure re-analysis of MLA105-120 
The crystal structure of MLA105-120 reported by Maekawa et al (12) shows a helix-loop-helix structure 
that forms a dimer through a large interface. There is an unusual chain-break in helix α2, where five 
residues (91–95) could not be modelled due to the absence of electron density (12). This size of the 
interface and favourable interactions between residues from different monomers led the authors to 
suggest that the association would likely be permanent. By contrast, our solution studies of the 
equivalent protein do not support the formation of a stable dimer. To investigate possible reasons 
for the crystallization of the dimer, we attempted to crystallize the analogous protein construct 
under different experimental conditions to those previously defined. We found that MLA105-120 
formed crystals in a large number of chemically diverse conditions. As the published MLA105-120 
structure was crystallized at low pH (4.6) and high salt (2.0 M sodium formate), we decided to 
investigate crystal-forming conditions that involved a different type of precipitant and more neutral 
pH (MIB buffer pH 7.0 (42), 25% PEG 1500). These crystals diffracted X-rays to ~2.0 Å. However, 
attempts to determine the structure by molecular replacement, using the structures of the CC 
domains of either MLA10  (49) or Rx (21) as search models, were not successful. The protein was 
subsequently expressed to incorporate seleno-methionine instead of methionine, and the structure 
was determined by single-wavelength anomalous diffraction (SAD) (for further details see Methods 
and Appendix Table 4.3). 
We were able to model all the protein residues (5–120), including the previously undefined region, 
residues 91–95, (Figure 4.3, Appendix Table 4.3), and the resolved MLA105-120 structure resembles 
closely the structure described previously (49). The dimeric interface identical to the one described 
previously (49) was also found in our crystal structure. Therefore, although we were able to obtain 
independently a very similar crystal structure to that of Maekawa and colleagues (49), the crystal 
structure remains inconsistent with our observations of the molecular weight calculations of 
MLA105-120 in solution. 
94 
 
 
 
Figure 4.3 Cartoon representation of the crystal structure of MLA105-120. (A) Crystal structure of two 
MLA105-120 monomers (yellow and orange) in cartoon representation, with the individual helices and 
N- and C-termini labelled. Five residues (91–95) could not be modelled due to the absence of 
electron density, and were drawn by dashed line in orange between helix α1 and α2. The conserved 
EDVID motif is shown in stick representation. (B) 90° rotation around the y-axis of (A). Structural 
statistics found in Appendix Table 4.3.  
 
4.6.4 CC domains form compact and globular structures in solution 
SEC-SAXS data also contains information on the particle shape in solution, and we proceeded to 
investigate the solution structures of the CC-domain proteins. The scattering from the tail fractions 
of all three proteins is indistinguishable within the experimental errors (Figure 4.4A), and their 
calculated properties (Appendix Table 4.2) and real-space distributions also agree (Figure 4.4B). 
Moreover, the experimental data is consistent with the predicted scattering of the four-helix bundle 
arrangement observed in the structures of Sr336-120 and Rx1-122, and is inconsistent with the 
structures of both the dimer and individual protomers from the MLA105-120 crystal structure (Figures 
4.4C–E, Appendix Table 4.4). These fits can also be visualized if ab initio reconstructions from the 
SAXS data are superimposed onto the corresponding high-resolution structures (Figure 4.4F). All 
(A) 
(B) 
95 
 
three data-sets yield compact, globular shape envelopes, into which the NMR structure of Sr336-120 
and the crystal structure of Rx1-122 can be docked with good agreement. These envelopes are clearly 
smaller than the extended conformation seen in the MLA105-120 crystals. The datasets collected at 
the peak centres are affected by self-association, rendering these unsuitable for modelling, and they 
do not compare well to any individual CC structure (Appendix Table 4.4). Collectively, the data 
suggests that the monomeric forms of Sr336-120, MLA105-120 and Rx1-122 all adopt compact, globular 
conformations, which are consistent with the four-helix bundle structure.  
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Figure 4.4 SAXS data from monomeric fractions of Sr336-120, MLA105-120 and Rx1-122 is consistent with 
compact, globular particles. (A) Data-sets from SEC-SAXS are shown as coloured lines, with the 
MLA105-120 and Rx1-122 data scaled to overlay with the Sr336-120 data. (B) Normalized distance 
distribution functions, P(r), are shown as coloured lines matching the scattering curve from which 
they were calculated. All distributions have been scaled to the maxima of the highest peaks. (C–E) 
SEC-SAXS data-sets again plotted as coloured lines. Experimental errors are displayed at 1σ in lighter 
colours. The theoretical scattering predicted from each 3D structural models is shown as a black line 
against the corresponding data-set. (F) The first member of the Sr336-120 NMR ensemble (blue), the 
Rx1-122 crystal structure (red) and the dimeric MLA105-120 crystal structure (yellow) are shown in 
cartoon representation, docked into ab initio envelopes calculated from their respective scattering 
data-sets. Ab initio models are shown in transparent surface representation, with the average model 
from 16 independent runs shown in light grey and the filtered model in darker grey. Divergence 
between the MLA10 crystal structure and the SAXS envelope is clear. 
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4.6.5 Extended CC domain fragments of Sr33 and MLA10 CC domains show an increased propensity 
to self-associate 
According to secondary-structure predictions (50), residue 120 of both Sr33 and MLA10 resides 
within a helix that is predicted to extend until residue 138 (Appendix Figure 4.4).  Recent in planta 
results indicate that the residues between 120–160 are required for signalling and self-association 
(51). Consequently, we expressed in E. coli, purified and prepared these larger fragments of the CC 
domains for analysis by SEC-MALS. A modified purification buffer system was necessary for 
purification (see Methods). We were able to purify Sr336-144, Sr336-160 and MLA105-144 to homogeneity 
(Figure 4.5B, D), but the MLA105-160 fragment was largely insoluble.  
SEC-MALS revealed an increasing propensity for self-association in the longer CC domain fragments 
(Figures 4.5A, C). The behaviour of Sr336-120 and MLA105-120 remained consistent with that reported 
in the previous experimental setup (Figures 4.2A, C, E).  For Sr33, an earlier peak with a molecular 
weight near the expected dimeric size was apparent for Sr336-144 and more pronounced for Sr336-160 
(Figure 4.5B). A larger peak at the expected monomeric size was still present for both. MLA105-144 
showed a single peak that was much more extended and asymmetric than that observed in   
MLA105-120, and with a molecular weight 40% higher than the expected monomeric weight. These 
experiments demonstrate that extended CC constructs of both Sr33 and MLA10 undergo self-
association in vitro, resulting in a mix of monomeric and dimeric species. Despite this, the 
monomeric forms remain the predominant forms in all constructs.    
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Figure 4.5 Solution studies of CC domains with extended sequences of Sr33 and MLA10. (A, C) 
Molecular-weight calculations from SEC-MALS analysis for Sr336-120, Sr336-144 and Sr336-160 (A); and 
MLA105-120 and MLA105-144 (C). Solid-grey, dark-grey and black lines represent the refractive index for 
the three proteins, respectively, when eluted from an in-line Superdex 200 5/150 GL column [GE]; 
these have been normalized to the height of the major peak for clarity. Dotted lines indicate the 
predicted molecular weights of both monomeric and dimeric species, and coloured lines show the 
experimental molecular-weight distributions as determined by MALS.  (B, D) Coomasie blue-stained 
SDS-PAGE of purified (left to right) Sr336-120, Sr336-144 and Sr336-160 (B); and MLA105-120 and MLA105-144 
(D) proteins, used in solution studies. (E) Summary of predicted and experimental average molecular 
weights for all constructs as determined by MALS. 
 
 
Theoretical MW 
(kDa) 
Experimental MW (kDa) 
Construct Monomer Dimer 
Shoulder 
peak 
Main peak 
Sr336-120 13.12 26.24 - 13.9 
Sr336-144 15.94 31.88 27.3 17.5 
Sr336-160 17.65 35.30 35.0 19.3 
MLA105-120 13.28 26.56 - 13.4 
MLA105-144 16.17 32.34 - 22.8 
E 
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4.6.6 Defining the minimal CC-domain signalling unit in Sr33, MLA10 and Sr50 
In light of our findings and those by Cesari and colleagues (49), we set out to identify the minimal N-
terminal fragment necessary for the signalling function of MLA10, Sr33 and Sr50, a close homolog of 
Sr33 isolated from Rye (52).  We generated six truncations of MLA10, Sr33 and Sr50 N-terminal 
domains within the region equivalent to MLA10 residues 120–160, at positions surrounding the 
predicted end of the α4 helix (1–130, 1–135, 1–141, 1–142, 1–144 and 1–148) (Figure 4.5A). These 
N-terminal fragments were transiently expressed in N. benthamiana under the control of the 35S 
promoter and fused to a C-terminal HA tag. These results showed that fragments truncated at, or 
beyond, the equivalent of MLA10 residue 142 were auto-active and induced cell death while shorter 
fragments were inactive (Figure 4.6A). The MLA101-160:CFP, Sr331-160:CFP and Sr501-163:CFP constructs 
were used as positive controls and triggered cell death (49). Immunoblotting showed that all fusion 
proteins were properly expressed (Appendix Figure 4.5A). Taken together, these results identify the 
minimal N-terminal cell death signalling domains of MLA10, Sr33 and Sr50 as extending to amino-
acid position equivalent to 142 in MLA10. 
 
4.6.7 Auto-active fragments of MLA10, Sr33 and Sr50 self-associate in planta 
To investigate whether association in planta, indicated by induction of cell death, was correlated 
with a measure of in vitro association, we performed co-immunoprecipitation (co-IP) experiments 
using fragments of MLA10, Sr33 and Sr50 equivalent to MLA10 1–141, 1–142 and 1–144 fused to 
CFP or HA tags (Figure 4.6B). CFP-fused CC fragments were expressed (Appendix Figure 4.5B) and 
displayed equivalent cell death activity as corresponding HA-tagged fragments (Appendix Figure 
4.5C). Proper expression of all proteins in the input was verified by immunoblotting using anti-GFP 
and anti-HA antibodies (Figure 4.6B). CFP-fused proteins were enriched after immunoprecipitation 
with anti-GFP beads and HA-fused auto-active fragments of MLA10, Sr33 and Sr50 co-precipitated 
with their respective CFP-fused fragment. However, they did not co-precipitate, or to a weaker 
background extent, with the RGA41-171:CFP construct (53) that was used as a negative control for 
binding specificity. Interestingly, self-association was highly reduced in the case of inactive CC 
domains. The Sr501-163 construct was used as a positive control for in planta self-association (49). 
Taken together, these results show that auto-active CC fragments of MLA10, Sr33, and Sr50 form 
specific homo-complexes in planta while inactive fragments do not self-associate, or do so to a 
limited extent. Therefore, these data indicate a clear correlation between self-association and in 
planta signalling activity. 
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Figure 4.6 Minimal autoactive domains of MLA10, Sr33, and Sr50 self-association in planta. (A) The 
indicated fragments of the MLA10, Sr33, and Sr50 proteins fused to HA or CFP were transiently 
expressed in N. benthamiana leaves by A. tumefaciens infiltration. The autoactive MLA101-160:CFP, 
Sr331-160:CFP, and Sr331-163:CFP constructs were used as positive controls. Cell death was visualised 
five days after infiltration. Equivalent results were obtained in 3 independent experiments. (B) The 
indicated fragments of MLA10, Sr33, and Sr50 fused to CFP or HA tags were transiently expressed in 
N. benthamiana leaves. Proteins extracted 20 hours after infiltration were analysed by 
immunoblotting with anti-HA (α-HA) and anti-GFP antibodies (α-GFP). Proteins were 
immunoprecipitated with anti-GFP beads (IP-GFP) and analysed by immunoblotting with anti-GFP 
and anti-HA antibodies. The CC domain of RGA4 fused to the CFP was used as a control for 
specificity, and the Sr501-163 construct was used as a positive control in each experiment (45). 
Ponceau staining of the RuBisCO large subunit shows equal protein loading in the input.      
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4.7 Discussion 
4.7.1 Conservation of a plant NLR CC domain structure 
Prior to this study, the partial structures of two plant CC domains had been reported. The four-helix 
bundle structure of the CC domain from the potato NLR protein Rx is ‘strikingly different’ (21) from 
the dimeric helix-turn-helix structure of the CC domain from the barley NLR protein MLA10 (12). 
Given the low sequence identity between MLA10 and Rx within the structured region (~18%) and 
the fact that Rx1-122 was crystallized in complex with a fragment of its co-factor, it was perhaps not 
surprising that the two proteins would adopt different conformations. Hao and co-workers (21) 
noted that the identification of any representative structure for the class would require 
characterization of further CC structures. Interestingly, such variation has not been observed among 
TIR-domains, the other class of plant NLR N-terminal domains. These have so far been found to 
adopt a conserved fold even between members with low sequence identities, raising the possibility 
that the plant NLR CC domains may adopt more diverse roles, functions and mechanisms of 
signalling than the TIR domains. 
However, it is surprising that the NMR structure of the Sr336-120 CC domain presented here revealed 
a compact four-helix bundle similar to the crystal structure of the Rx CC domain (18% sequence 
identity) (21), rather than the dimeric arrangement in the crystal structure of MLA10 (~82% 
sequence identity) (49). Biophysical characterization using SEC-MALS and SAXS confirmed 
predominantly monomeric behaviour in solution for Sr336-120, Rx1-122, and unexpectedly, also    
MLA105-120. Some limited self-association was observed in SEC-SAXS experiments for Rx1-122 and 
MLA105-120, but not what would be expected for an obligate dimer suggested by the crystal structure 
for MLA105-120 (12). In addition, the monomeric fractions of all three samples were indistinguishable 
by SEC-SAXS shape analysis, and were consistent with the 4-helix bundle structures of the Sr336-120 
and Rx1-122, but not the dimeric MLA105-120 crystal structure. These data suggest that plant NLR CC 
domains may have conserved structures, as is the case for TIR domains.  
 
4.7.2 Self-association and CC domain signalling 
Highly relevant to this work is the recent discovery that constructs of Sr33 and MLA10 comprising 
residues 1–120 of the CC domain do not co-IP in planta, consistent with our finding that Sr336-120 and 
MLA105-120 do not self-associate in solution. More importantly, these truncated constructs also did 
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not induce a cell-death phenotype when transiently expressed in tobacco. Longer constructs 
comprising residues 1–160 were capable of both in planta co-IP and cell-death activity. 
Our solution studies using these longer active constructs showed that the inclusion of additional 
residues at the C-terminus (MLA105-144, Sr336-144 and Sr336-160) facilitates self-association, 
corroborating the link between self-association and signalling for these proteins. It is, however, 
important to note that even the longest constructs retained a large fraction of monomeric protein in 
solution, suggesting that both monomer and dimer forms are present.   
Building upon this, we demonstrated using transient assays in tobacco that for Sr33, MLA10 and the 
related wheat NLR Sr50, the minimal functional unit for cell-death signalling extends to a position 
that coincides with the predicted end of the last α-helix within the CC domain. In addition, co-IP 
experiments demonstrated that any constructs that were capable of causing cell death could also 
self-associate when expressed in planta. Collectively, these results establish a correlation between 
self-association and biological activity and suggest that self-association is the switch regulating cell-
death induction. 
 
4.7.3 The coiled-coil dimer 
It is important to address the tendency of MLA105-120 to crystallize in a dimeric conformation, as well 
as the conflicting evidence for such a dimer in solution. Maekawa and colleagues suggested    
MLA105-120 existed as a dimer in solution, based on the crystal structure, the slow migration by SEC, 
the appearance of cross-linked bands following incubation with a chemical crosslinking agent, and 
the insolubility of recombinant protein after the putative dimer interface was disrupted by mutation 
(12). We were able to independently confirm the results of crystallography, SEC and cross-linking, 
suggesting the conflicting observations require explanation. Migration by SEC is often used to 
estimate molecular weights of proteins by comparison to protein standards of known molecular 
weights; however, the migration is influenced by particle shape, flexibility and composition. By 
contrast, determination of molecular weight using MALS and SAXS techniques relies on absolute 
measurements, and while there is no ideal method, these approaches provide a more robust and 
quantitative means of molecular-weight measurement than migration by SEC (35,54,55). In the case 
of MLA105-120, these methods show only a small degree of transient self-association. Consistent with 
these data, MLA105-120 remains predominantly monomeric even after extended incubation with a 
crosslinking agent and the observed behaviour is likely more indicative of weak self-association than 
an obligate interaction.  
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Similarly, the process of crystallization selects for states that will promote a highly ordered 
arrangement in the crystal. The comparison pf the dimer observed in the crystals to the four-helix 
bundle structures suggests that the monomers may have undergone a domain swap in the 
crystallization solution. Figure 4.1 shows that it is possible to superimpose two copies of the Sr336-120 
four-helix bundle side-by-side onto the MLA10 dimer. Repositioning α1 and α4 in Sr336-120 to form a 
continuous helix would regenerate the helix-loop-helix observed in the MLA105-120 dimer, while 
retaining all the same internal hydrophobic contacts. Importantly, this also explains the insolubility 
of the interface-disrupting mutants. The residues that form the dimeric interface also form the 
hydrophobic core of the four-helix bundle monomer, and the same mutations would also disrupt the 
monomeric fold and render the protein insoluble. Domain swapping is quite common (56), and may 
be caused by the dynamic behaviour of the protein that could reflect conformational transitions that 
have functional significance in signalling. 
Our results demonstrate that extensions to residue 144 in both Sr33 and MLA10 are necessary for 
consistently measurable self-association in solution. Importantly, this self-association is highly 
correlated with signalling activity. This tight correlation suggests that it is the dimeric form that is 
responsible for cell death signalling of the CC domain. However, the nature of this dimer is not clear.  
While it remains plausible that the MLA105-120 crystal structure captures some part of the activated 
signalling dimer, it is also possible that the additional C-terminal residues promote self-association of 
the protein in the four-helix-bundle conformation instead. Based on our data, we favour the latter of 
these explanations. Importantly, the measured molecular weight of MLA105-144 from SEC-MALS 
analysis is between the expected sizes of the monomeric and dimeric forms of the protein. 
Interestingly, Sr336-160 shows evidence of such a separated dimeric peak, albeit only a small 
proportion of the protein is dimeric (Appendix Figure 4.3B). Clearly, a full structural exploration of 
the longer, active constructs will be necessary to reveal the conformation of these dimers and the 
protein-protein interfaces that control their formation.  
 
4.7.4 Mechanism of signalling by NLR CC domains 
It has been hypothesized that the self-association of the TIR domains post-activation is positively 
regulated via self-association of other domains from the full-length plant NLR (57). There is a 
precedent for self-association of NB and LRR domains in animal NLRs (17-19), although this has yet 
to be observed structurally in plant NLRs. We propose a similar model of signalling for the CC-NLRs, 
in which the transient self-association of the CC domain is stabilized by the full-length NLR in order 
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to achieve the activated state. These associations would presumably facilitate the recruitment of 
downstream signalling molecules, as is the case in animal NLRs (17-19,58) and Toll-like receptors 
(59). 
Our study demonstrates that both distantly and closely related CC-NLR proteins have structurally 
similar CC domains, reconciling previously conflicting data and models of activation of this important 
domain. We show that self-association of CC domains is highly correlated with cell-death activity in 
the MLA10 and Sr33 CC-NLR proteins, and we define residues comprising a minimal-functional unit 
both biophysically and in planta. Collectively, this data redefine our structural understanding of the 
CC domains from CC-NLR proteins. It is anticipated that this work will provide a platform for further 
structural studies of the full-length CC domains and illuminate the molecular details of the homo-
interactions that are associated with defence signalling.  
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4.9 Chapter 4 appendix 
Appendix Table 4.1 NMR structure statisticsa 
 
aAll statistics are given as mean ± SD. 
bOnly structurally relevant restraints, as defined by CYANA, are included.  
cMean r.m.s. deviation calculated over the entire ensemble of 20 structures. 
dAs reported by CYANA (31,32). 
  
Experimental restraintsb  
 Inter-proton distance restraints  
 Intra-residue  580 
 Sequential 186 
 Medium-range (i–j < 5) 293 
 Long-range (i–j > 5) 249  
 Dihedral-angle restraints 214 
 Total number of restraints per residue 12.96 
RMSD from mean coordinate structure (Å)c  
 Backbone atoms (residues 6–89 & 98–110) 0.93 ± 0.21 
 All heavy atoms (residues 6–89 & 98–110) 1.31 ± 0.19 
Stereochemical qualityd  
 Residues in most favoured Ramachandran region (%)  93.1 
 Ramachandran outliers (%) 0 ± 0 
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Appendix Table 4.2 Properties derived from averaged SAXS datasets 
Protein Fraction Elution range 
(mL) 
I(0) Guin 
(cm-1) 
I(0)P(r) 
(cm-1) 
Rg Guin 
(Å) 
Rg P(r) 
(Å) 
MWVc 
(kDa) 
MWPorod 
(kDa) 
Sr335-120 Centre 11.77 – 12.31 4.00 e-2 4.09 e-2 17.73 18.81* 14.1 16.3 
Tail 12.35 – 12.69 1.28 e-2 1.28 e-2 17.08 17.19 13.5 13.9 
MLA105-120 Centre 9.29 – 10.04 3.69 e-2 3.76 e-2 20.81 22.27* 16.1 25.0 † 
Tail 10.42 – 11.29 0.46 e-2 0.46 e-2 17.72 17.62 13.7 15.5 
Rx1-122 Centre 9.48 – 10.07 3.95 e-2 4.01 e-2 21.35 22.63* 16.3 25.0 † 
Tail 10.65 – 11.32 0.31 e-2 0.31 e-2 17.10 17.38 13.7 15.1 
 
* Values for Rg P(r) that differ from Rg Guin by greater than 5% 
† Values for MWPorod that differ from MWVc by greater than 15% 
The theoretical monomeric molecular weights of Sr335-120, MLA105-120 and Rx1-122 are 13.2 
kDa, 13.4 kDa and 14.3 kDa, respectively. 
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Appendix Table 4.3 Crystallographic table for MLA105-120  
Data processing  
Space group P 2 21 21 P 1 
a, b, c (Å) 30.87 87.56 92.56 
 
 
, ,  (°) 90 90 90  
Resolution (Å) 46.28-2.1 (2.16–2.10)  
Rmeas(%) a 0.11 (1.94)  
Rpim(%) b 0.03 (0.51)  
<I/(I)> 15 (1.8)  
CC1/2
c 0.99 (0.89)  
Completeness (%) 100 (100)  
Multiplicity 14.1 (14.4)  
Wilson plot B (Å2) 44.7  
Observations 216711 (18084) 
 (13863) 
 
Unique reflections 15392 (1253) 
 (1881) 
 
Anomalous completeness 100 (100)  
Anomalous multiplicity 7.7 (7.7)  
DelAnom correlation between 
half-sets 
 
0.471 (-0.027)  
Mid-Slope of Anom Normal 
Probability 
 
1.087  
Estimate of maximum resolution for significant anomalous signal = 3.59A, from CCanom > 0.15 
 
Refinement  
Rwork (%)  24.5 
Rfree (%)  27.8 
Average B-factor (Å2)  56.6 
R.m.s deviations  
Bond lengths (Å)  0.0101 
Bond angles (°)  1.08 
Ramachandran plot (%) d  
Favoured  97.95 
Allowed  1.71 
Outliers  0.34 
a Rmeas = ∑hkl{N(hkl)/[N(hkl)-1]}
1/2 ∑i|Ii(hkl)- <I(hkl)>|/ ∑hkl∑iIi(hkl), where Ii(hkl) is the intensity of the ith 
measurement of an equivalent reflection with indices hkl. 
b Rpim = ∑hkl{1/[N(hkl)-1]}
1/2 ∑i|Ii(hkl)- <I(hkl)>|/ ∑hkl∑iIi(hkl). 
c Calculated with the program Aimless (45) 
dAs calculated by MolProbity (60) 
NB: Values within parentheses indicate the highest resolution bin. 
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Appendix Table 4.4 Goodness-of-fit (χ) scores for averaged SAXS datasets compared to structures 
 
  Atomic structure (PDB ID) 
Sample Fraction 
Sr336-120 Rx1-122 MLA105-120 
NMR* 4M70 
3QFL 
monomer 
3QFL 
dimer 
Sr335-120 Tail 0.67 1.63 12.03 8.41 
MLA105-120 Tail 0.51 0.87 3.99 2.88 
Rx1-122 Tail 0.48 0.73 3.44 2.71 
Sr335-120 Centre 2.47 7.36 31.62 20.54 
MLA105-120 Centre 7.24 14.30 19.02 12.60 
Rx1-122 Centre 7.52 14.59 17.85 11.66 
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Appendix Figure 4.1 Ensemble of twenty super-imposed lowest-energy NMR structures of Sr336-120. 
 
  
110 
 
 
Appendix Figure 4.2 Analysis of scattering curves averaged over the peak centre and dilute fractions 
from SEC-SAXS. (A, C, E) Experimental datasets are plotted as coloured lines, with experimental 
errors displayed at 1σ in lighter colour. Solid black lines indicate the fit of the corresponding distance 
distribution. The datasets are arbitrarily offset along the y-axis for ease of visualization. (B, D, F) 
Normalized distance distribution functions, P(r), are shown as coloured lines matching the scattering 
curve from which they were calculated. P(r)s have been normalized to reciprocal-space zero-angle 
intensity. The Guinier regions of the datasets are shown in the insets, transformed as q2 vs ln I(q). 
Individual data-points are plotted as coloured diamonds, and a linear regression fit to each is shown 
as a black line. The datasets are again offset in y for visualization.  
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Appendix Figure 4.3 Purification and SEC analysis (A) Coomassie blue-stained SDS-PAGE of purified 
proteins (left-right) Mla105-120, Rx1-122 and Sr336-120 proteins. (B) Mla105-120 (orange), Rx1-122 (red) and 
Sr336-120 (blue) were separated on a Superdex S75 10/300 size-exclusion chromatography column 
and compared with known standards chymotrypsin (25 kDa) and cytochrome c (12 kDa) (dashed 
lines). (C) Chemical crosslinking of Mla105-120. The protein was incubated with the cross-linker BS3 
and sampled at time points 0, 10, 30, 60, 120 min. (-) represents the protein without BS3 added. The 
protein samples were separated by SDS-PAGE and Coomassie blue-stained. 
  
112 
 
 
Appendix Figure 4.4 Secondary structure prediction of Mla10, Sr33 and Sr50 CC domains from 
protein sequences using PSIPRED (61,62). Construct boundaries are marked with dashed lines.  
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Appendix Figure 4.5 HA and CFP-tagged CC fragments of MLA10, Sr33 and Sr50 are expressed in N. 
benthamiana. (A, B) Indicated proteins were extracted from transiently transformed N. 
benthamiana leaves 20 hours after infiltration and were analyzed by immunoblotting with anti-GFP 
or anti-HA antibodies. Ponceau staining of RuBisCO was used to verify equal protein loading. (C) 
Indicated constructs were transiently expressed in N. benthamiana. Cell death was visualized five 
days after infiltration.  
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5.1 Conclusions 
5.1.1 Project achievements overview 
The research presented in this thesis has furthered the understanding of the human innate immune 
signalling protein MAL and plant innate immune receptor protein Sr33. Study of these proteins has 
focused on structural analysis and has been summarised by a flow-diagram of achievements, which 
is shown in Figure 5.1.  
         MAL TIR domain                        SR33 coiled-coil domain 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Flow diagram of project achievements for the MAL TIR domain and the Sr33 coiled-coil 
domain.  
  
5.1.2 The biochemistry and structure of the human MALTIR 
In this thesis, studies on the biochemistry of the MALTIR have shown that in solution, the protein 
exists in a dynamic equilibrium between a monomer and oligomer. The state of this equilibrium is 
dependent on a number of factors, which include: the concentration of salt, concentration of 
protein, temperature, and pH of the solution. This can be reversed by changing any one of these 
factors. For example, by lowering the temperature from 20°C to 4°C while keeping other factors 
constant, the equilibrium will shift to favour the monomeric state. Given that the association 
between TIR domains has been shown to promote signalling, as in TLRs, the identification of a 
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reversible oligomer formation by MALTIR suggests that this is an important feature that contributes 
to its functioning. During the purification, a small portion (<10%) elutes as a dimer while the rest is 
monomeric. This dimer is not in equilibrium with the monomer, such that if re-eluted over the size-
exclusion column, the protein only elutes as a dimer. In addition, the dimer is not dependent on 
reduction or ionic strength for its interaction. SAXS data from this thesis has shown that the dimer 
which is measured does not correspond to the interfaces observed in the crystal structure of MALTIR 
(1). This collective evidence suggests that this may be a domain-swap dimer, whose physiological 
relevance is unclear. 
Data presented here indicates that in solution, the structure of MALTIR is different to that of the 
previously published crystal structures (1-4). The MALTIRC116A mutant has shown to be more stable as 
a monomer in solution than the wild-type, while still possessing the same fold in solution. As a 
result, a NMR solution structure of the MALTIRC116A mutant has been solved. Overall, this solution 
structure contains five α-helices, which surround a five-stranded anti-parallel β-sheet, with a long 
BB-loop situated between the βB-strand and αB-helix. The arrangement of the β-strands and α-
helices in this solution structure of MALTIRC116A is consistent with a typical TIR domain (5). In context, 
discovery of the BB-loop in the MALTIRC116A solution structure presented here is striking as this is an 
important feature of TIR domains and has been associated with protein interactions (6-8). In 
support, earlier mutation studies of residues in this region have shown a significant decrease in the 
activation of pro-inflammatory transcription factor NF-B (2). This structure now provides a new 
template for modelling approaches and future mutational studies for functional study. Furthermore, 
the addition of a BB loop and lack of the AB loop in the solution structure suggests that the AB loop 
in the crystal structure could be the oxidised form of the protein.  
Previously published crystal structures of MALTIR contained a mixture of reduced and oxidised 
cysteine residues with four cysteines participating in two disulfide bonds (1-4). Biochemical assays 
presented in this thesis showed that the redox state of cysteine residues could indeed be changed. 
Exposure to reducing environments such as DTT and E. coli BL-21 cells resulted in mostly reduced 
cysteine residues, while growth in E. coli SHuffle, Origami, and exposure to hydrogen peroxide 
produced mostly oxidised cysteine residues. Data from chemical shifts of all seven cysteine residues 
as well as intact mass spectrometry strongly suggest that the cysteine thiols are reduced in solution 
following purification from a reducing cell type such as E. coli BL-21. Given that the cytosol of a 
human eukaryotic cell is reducing, it is not surprising that the seven cysteines, which are all exposed 
to solvent, are also reduced. 
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Redox studies in this thesis have indicated that these cysteine residues have very different 
reactivates when exposed to a change in the redox condition. A physiological redox range from a 
reducing (-225 mV) to oxidising (-190 mV) was assessed. As expected, at -225 mV, all cysteine 
residues were reduced. This was consistent with the solved solution structure of MALTIRC116A. 
Strikingly, as the condition changed to an oxidising -190 mV, half of population belonging to cysteine 
91 became oxidised. Given that this residue is involved in coordinating a redox sensitive molecule in 
the crystal structures, this result suggests that the residue is highly reactive under physiological 
conditions and may point to functional importance. 
Mass spectrometry from this research has also demonstrated that all cysteine residues in MALTIR can 
be modified by glutathione; a key redox molecule in the cell cytoplasm. Redox modifications such as 
glutathionylation of cysteine residues in cytosolic proteins have been previously shown to be critical 
in modulating the functionality of proteins (9). Early work has indicated that association of 
glutathione transferase protein GSTO-1 with other proteins in the early TLR pathway significantly 
affects the downstream activation of pro-inflammatory transcription factor NF-B (10). In addition, 
the redox state of the cell cytoplasm has been reported to become more oxidising upon the 
stimulation of the human innate immune TLR4 pathway (11,12). Given that the MAL protein is 
associated with the TLR4 pathway, it is likely that the cysteine residues of MALTIR, especially C91, 
undergo redox change, which modulates the protein’s ability to signal.  
 
5.1.3 The structure of the Sr33 coiled-coil domain 
Two crystal structures of coiled-coil domains from two plant innate immune receptor proteins, 
namely Rx (13) and MLA10 (14), have shown crystal structures that are very different to each other. 
This thesis presents the monomeric NMR solution structure of the wheat Sr33 coiled-coil domain, 
which is modelled as a bundle of four α-helices. Three of these helices consistently show strong 
evidence for close association, while one helix (α4) at the C-terminus, is weakly associated with the 
remaining three helices. Given that the solution structure of the Sr33 coiled-coil domain is truncated 
at the C-terminus, such that the domain is no longer active as shown by Cesari et al (unpublished), it 
is possible that a longer construct which extends off the α4 helix contains important structural 
information. This would provide a functional reason for the weak binding α4 helix, which is currently 
unknown. The results presented here show that the Sr33 coiled-coil domain contains the conserved 
EDVID motif (EDAVD in Sr33) on the solvent accessible surface of α3 helix, which has been previously 
identified as an important motif for protein interactions (15). Taken together, this structure has 
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identified two features including, a weak binding α4 helix and the EDVID motif, that are consistent 
with the notion that the coiled-coil domain of Sr33 forms a signalling scaffold for downstream 
signalling.    
 
5.2 Future Directions 
5.2.1 Future directed studies of the MALTIR 
In this thesis, two aspects of the MALTIR behaviour are presented. This includes the ability of cysteine 
residues to change redox state and the ability to form larger oligomeric structures. The future work 
of these aspects, which will build upon the work presented in this thesis, will be discussed, as well as 
preliminary results that have been obtained for the these future studies. 
 
5.2.2 In-vivo redox changes of MALTIR 
Redox modification of cysteine residues in cytosolic proteins is an important regulatory mechanism 
of signalling. In this study, the solution structure of the MALTIRC116A revealed seven reduced cysteine 
residues, which are able to undergo oxidation in-vitro. Further in-vivo studies are required to 
investigate the physiological relevance of the redox change on these cysteine residues. Multi-
dimensional in-cell NMR experiments have shown that isotopically double-labelled protein can be 
used to determine chemical shifts of 1H, 15N and 13C atoms (16). A study comparing protein insertion 
methods into human cell lines has found electroporation to be the most efficient method to insert 
labelled protein into human HEK-293T cells (17). Preliminary in-vivo results using this method have 
been successful and are presented in the following sections. 
 
5.2.3 MALTIR is taken up by mammalian cells 
Following expression in E. coli BL-21 bacterial cells, and purification using nickel affinity and size-
exclusion chromatography, the wild-type myc-tagged MALTIR was mixed in a 1:1 ratio with 
Dulbecco’s modified eagle medium (DMEM) [Thermo Fisher Scientific]. HEK-293T cells were grown in 
a two T7 flask until confluent (2×107 cells), washed with phosphate buffered saline (PBS) solution 
and electroporated with the protein in a total volume of 100 µL at 250 V and 250 µF. The cells were 
then washed to remove protein on the cell surface and rested with fresh DMEM media for four 
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hours. Western blot of the cell lysate following electroporation showed that the protein was taken 
up by the cells (lane 4 in Figure 5.2). Comparatively, two-thirds of the protein still remained in the 
electroporated solution without being taken-up by the cells, as shown by lane 3 in Figure 5.2.  
                                        
Figure 5.2 Western blot showing the up-take of MALTIR, which has been tagged with a Myc-tag for 
electroporation into mammalian HEK-293T cells. The gel shows that the protein has been taken up 
by the cell as shown in lane 4.  
 
5.2.4 Localisation of MALTIR in mammalian HEK-293T cells  
Following electroporation of the GFP-tagged MALTIR into mammalian HEK-293T cells using the 
protocol above, conventional wide-field and confocal fluorescence microscopy was performed to 
confirm up-take and localisation of the protein. Fluorescence images in Figure 5.3 show that GFP-
MALTIR has been taken up by the cells. The GFP-MALTIR protein is in two forms in the cell; 
concentrated in a single high intensity particle, and dispersed evenly throughout the cell. Protein 
that has been encapsulated by an endosome reflects a higher signal intensity unit compared to 
cytoplasmic protein, which is evenly dispersed. Visually, the majority of the protein appears to be 
dispersed throughout the cell cytoplasm. In general, most of the cells have taken up equal amounts 
of protein, with a few cells showing high intensity, indicating a high amount of protein present. A 
closer examination of cellular localisation was performed using confocal microscopy, shown in Figure 
5.4. Slices through HEK-293T cells show a distribution of fluorescence across the cell, indicating the 
GFP-MALTIR is present in the cytoplasm.   
 
 
1 2 3 4 
16 kDa 
1. Purified MALTIR 
2. MALTIR with DMEM media (1:1) 
3. Supernatant following 
electroporation 
4. Cell lysate following electroporation 
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Figure 5.3 Wide-field fluorescence microscopy images obtained following electroporation with 
either GFP-MALTIR or Myc-MALTIR tags and one wash with PBS.  
A GFP-MALTIR in HEK-293T cells  
B Far view of HEK-293T cells with GFP-MALTIR  
C Myc-MALTIR in HEK-293T cells (negative control)   
 
 
 
 
A B 
C 
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Figure 5.4 Confocal microscopy showing 0.5 µm slices through HEK-293T cells with GFP-MALTIR 
domain in cytoplasm. Slices through the cell show an even distribution of GFP-MALTIR throughout the 
cytoplasm.  
 
5.2.5 Future in vivo studies of MALTIR 
Preliminary results have confirmed that the protein had successfully entered the cell and the 
majority of the protein was indeed dispersed throughout the cytoplasm rather than in endosomes. 
Following this work, the next experiment would focus on confirming that the protein had indeed 
retained structure. It is unknown if the protein is stable in DMEM media and through the 
electroporation process. In addition, eukaryotic cells are continuously undergoing metabolism, 
which could contribute to the rapid digestion of the protein. Correct protein folding can be 
confirmed by 1H-15N-HSQC using 15N-labelled protein, by comparing the spectra of the E. coil-
produced purified protein with the electroporated intracellular protein. Further to this, it would be 
interesting to test the role of cysteine residues during TLR4 signalling. HEK-293T cells that contain 
TLR4 would be stimulated by lipopolysaccharides (LPS) and MD2, whilst containing electroporated 
15N and 13C labelled MALTIR. By observing the β-carbon atoms belonging to the cysteine residues 
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(18,19), the chemical shift changes will indicate whether the redox change of the cysteine residues is 
involved in the signalling function of the protein.  
  
5.2.6 Investigation of the MALTIR oligomer 
The interaction of TIR domains has been shown to be an important feature in the signal transduction 
of the human immune system (20). This study has shown that the MALTIR is in equilibrium between 
monomeric and oligomeric states. Given that this oligomer is likely to be key to downstream signal 
transduction that stimulates the human immune system, there is much interest in the structure of 
the MALTIR oligomer as well as the mechanism that regulates the formation of the MALTIR oligomer. 
Un-published data by Ve et al has used electron microscopy to observe the structure of the MALTIR 
oligomer. The NMR solution structure presented in this thesis has been modelled into the density 
provided by electron microscopy to understand the homotypic interactions of the MALTIR. In 
addition, it would be interesting to investigate if the oligomer is functionally relevant. This could be 
tested by electroporating GFP-MALTIR into HEK-293T cells followed by induction with LPS. This would 
then be viewed using confocal microscopy, which would show the localisation of GFP-MALTIR from 
the cytoplasm to the cell membrane, followed by electron microscopy, where the oligomer would be 
visualised as a snap-shot of the signalling process.   
 
5.2.7 Future directed studies of Sr33 coiled-coil domain 
This study has determined the solution structure of the Sr33 coiled-coil domain. The structure 
revealed a four helix bundle. Supporting data (manuscript of Chapter 4) has defined a minimal 
functional unit to be 22 residues longer than that which has been solved. Future work could focus on 
collecting, 1H, 15N and 13C resonances of the full Sr33 coiled-coil domain, which is functionally active, 
and obtain the structure to obtain functional insight. This would build on the current model 
presented in this thesis as the majority of the resonances could be transferred from the existing 
structure. Shown in Chapter 4, self-association of coiled-coil domains highly correlates with cell-
death. Currently there is little information on the nature of the interaction between coiled-coil 
domains at a molecular level. In-vitro NMR experiments using a mixture of labelled and unlabelled 
protein could be used to determine the interacting interface of these domains. In addition, the 
nature of binding could be determined by assessing chemical shifts and peak intensities, providing 
information on the binding affinity and structural changes that occur as a result of interaction. 
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Further to this, the solution structure of another coiled-coil receptor protein MLA10 could be solved, 
which contains a crystal structure that is very different to Rx and Sr33 coiled-coil receptors domain 
(14). Given that the solution structure of Sr33 presented in this thesis is consistent with another 
receptor coiled-coil protein structure, namely Rx (13), solving the solution structure of MLA10 
coiled-coil receptor which is structurally very different would begin to answer the role that the 
structure plays in protein interactions. 
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